<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.0 20040830//EN" "journalpublishing.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="2.0" xml:lang="en" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">J Med Internet Res</journal-id><journal-id journal-id-type="publisher-id">jmir</journal-id><journal-id journal-id-type="index">1</journal-id><journal-title>Journal of Medical Internet Research</journal-title><abbrev-journal-title>J Med Internet Res</abbrev-journal-title><issn pub-type="epub">1438-8871</issn><publisher><publisher-name>JMIR Publications</publisher-name><publisher-loc>Toronto, Canada</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">v28i1e76130</article-id><article-id pub-id-type="doi">10.2196/76130</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>The Phases of Living Evidence Synthesis Using AI: Living Evidence Synthesis (Version 1)</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Song</surname><given-names>Xuping</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lian</surname><given-names>Zhenjie</given-names></name><degrees>MSc</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wang</surname><given-names>Rui</given-names></name><degrees>MSc</degrees><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Li</surname><given-names>Ruixin</given-names></name><degrees>MSc</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yang</surname><given-names>Zhenzhen</given-names></name><degrees>MSc</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Luo</surname><given-names>Xufei</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff6">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Feng</surname><given-names>Lei</given-names></name><degrees>BSc</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ma</surname><given-names>Zhiming</given-names></name><degrees>BSc</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pu</surname><given-names>Zhen</given-names></name><degrees>BSc</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wang</surname><given-names>Qi</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff7">7</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ge</surname><given-names>Long</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Li</surname><given-names>Caihong</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chen</surname><given-names>Yaolong</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff6">6</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Yang</surname><given-names>Kehu</given-names></name><degrees>MSc</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lavis</surname><given-names>John</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff9">9</xref></contrib></contrib-group><aff id="aff1"><institution>School of Public Health, Lanzhou University</institution><addr-line>No. 222 South Tianshui Road, Lanzhou</addr-line><addr-line>Lanzhou</addr-line><addr-line>Gansu</addr-line><country>China</country></aff><aff id="aff2"><institution>The Centre of Evidence-based Social Science, Lanzhou University</institution><addr-line>Lanzhou</addr-line><addr-line>Gansu</addr-line><country>China</country></aff><aff id="aff3"><institution>Key Laboratory of Evidence Based Medicine &#x0026; Knowledge Translation of Gansu Province</institution><addr-line>Lanzhou</addr-line><addr-line>Gansu</addr-line><country>China</country></aff><aff id="aff4"><institution>WHO Collaborating Centre for Guideline Implementation and Knowledge Translation</institution><addr-line>Lanzhou</addr-line><addr-line>Gansu</addr-line><country>China</country></aff><aff id="aff5"><institution>Dingxi Center for Disease Control and Prevention</institution><addr-line>Dingxi</addr-line><addr-line>Gansu</addr-line><country>China</country></aff><aff id="aff6"><institution>Evidence-Based Medicine Center, School of Basic Medicine, Lanzhou University</institution><addr-line>Lanzhou</addr-line><addr-line>Gansu</addr-line><country>China</country></aff><aff id="aff7"><institution>School of Public Health, University of Hong Kong</institution><addr-line>Hong Kong</addr-line><country>China</country></aff><aff id="aff8"><institution>School of Information Science and Engineering, Lanzhou University</institution><addr-line>Lanzhou</addr-line><addr-line>Gansu</addr-line><country>China</country></aff><aff id="aff9"><institution>Department of Health Research Methods, Evidence, and Impact, McMaster Health Forum, McMaster University</institution><addr-line>Hamilton</addr-line><addr-line>ON</addr-line><country>Canada</country></aff><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Coristine</surname><given-names>Andrew</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name name-style="western"><surname>Bhagat</surname><given-names>Chinmaya</given-names></name></contrib><contrib contrib-type="reviewer"><name name-style="western"><surname>Ting</surname><given-names>Eon</given-names></name></contrib></contrib-group><author-notes><corresp>Correspondence to Kehu Yang, MSc, School of Public Health, Lanzhou University, No. 222 South Tianshui Road, Lanzhou, Lanzhou, Gansu, 753000, China, +86 13893117077, +86 13893117077; <email>yangkh-ebm@lzu.edu.cn</email></corresp></author-notes><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>27</day><month>1</month><year>2026</year></pub-date><volume>28</volume><elocation-id>e76130</elocation-id><history><date date-type="received"><day>17</day><month>04</month><year>2025</year></date><date date-type="accepted"><day>15</day><month>12</month><year>2025</year></date></history><copyright-statement>&#x00A9; Xuping Song, Zhenjie Lian, Rui Wang, Ruixin Li, Zhenzhen Yang, Xufei Luo, Lei Feng, Zhiming Ma, Zhen Pu, Qi Wang, Long Ge, Caihong Li, Yaolong Chen, Kehu Yang, John Lavis. Originally published in the Journal of Medical Internet Research (<ext-link ext-link-type="uri" xlink:href="https://www.jmir.org">https://www.jmir.org</ext-link>), 27.1.2026. </copyright-statement><copyright-year>2026</copyright-year><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research (ISSN 1438-8871), is properly cited. The complete bibliographic information, a link to the original publication on <ext-link ext-link-type="uri" xlink:href="https://www.jmir.org/">https://www.jmir.org/</ext-link>, as well as this copyright and license information must be included.</p></license><self-uri xlink:type="simple" xlink:href="https://www.jmir.org/2026/1/e76130"/><abstract><sec><title>Background</title><p>Living evidence (LE) synthesis refers to the method of continuously updating systematic evidence reviews to incorporate new evidence. It has emerged to address the limitations of the traditional systematic review process, particularly the absence of or delays in publication updates. The emergence of COVID-19 accelerated the progress in the field of LE synthesis, and currently, the applications of artificial intelligence (AI) in LE synthesis are expanding rapidly. However, in which phases of LE synthesis should AI be used remains an unanswered question.</p></sec><sec><title>Objective</title><p>This study aims to (1) document the phases of LE synthesis where AI is used and (2) investigate whether AI improves the efficiency, accuracy, or utility of LE synthesis.</p></sec><sec sec-type="methods"><title>Methods</title><p>We searched Web of Science, PubMed, the Cochrane Library, Epistemonikos, the Campbell Library, IEEE Xplore, medRxiv, COVID-19 Evidence Network to support Decision-making, and McMaster Health Forum. We used Covidence to facilitate the monthly screening and extraction processes to maintain the LE synthesis process. Studies that used or developed AI or semiautomated tools in the phases of LE synthesis were included.</p></sec><sec sec-type="results"><title>Results</title><p>A total of 24 studies were included, including 17 on LE syntheses, with 4 involving tool development, and 7 on living meta-analyses, with 3 involving tool development. First, a total of 34 AI or semiautomated tools were involved, comprising 12 AI tools and 22 semiautomated tools. The most frequently used AI or semiautomated tools were machine learning classifiers (n=5) and the Living Interactive Evidence synthesis platform (n=3). Second, 20 AI or semiautomated tools were used for the data extraction or collection and risk of bias assessment phase, and only 1 AI tool was used for the publication update phase. Third, 3 studies demonstrated the improvement in efficiency achieved based on time, workload, and conflict rate metrics. Nine studies applied AI or semiautomated tools in LE synthesis, obtaining a mean recall rate of 96.24%, and 6 studies achieved a mean <italic>F</italic><sub>1</sub>-score of 92.17%. Additionally, 8 studies reported precision values ranging from 0.2% to 100%.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>AI and semiautomated tools primarily facilitate data extraction or collection and risk of bias assessment. The use of AI or semiautomated tools in LE synthesis improves efficiency, leading to high accuracy, recall, and <italic>F</italic><sub>1</sub>-scores, while precision varies across tools.</p></sec><sec><title>Trial Registration</title><p>OSF Registries 87tp4; https://osf.io/4fvdq/overview</p></sec></abstract><kwd-group><kwd>accuracy</kwd><kwd>artificial intelligence</kwd><kwd>efficiency</kwd><kwd>living evidence synthesis</kwd><kwd>phases</kwd><kwd>semiautomated tools</kwd><kwd>utility</kwd></kwd-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Evidence synthesis refers to an approach where data across studies are identified and combined to gain a clearer understanding of a body of research [<xref ref-type="bibr" rid="ref1">1</xref>]. There is typically a significant gap between the time when a search is performed and the time when the results are published, often exceeding a year [<xref ref-type="bibr" rid="ref2">2</xref>]. Furthermore, only a limited number of reviews are updated once they have been published [<xref ref-type="bibr" rid="ref3">3</xref>]. This process can result in missing evidence, potentially affecting the accuracy of the findings. The approach of living evidence (LE) synthesis has been developed to address this challenge.</p><p>The method of constantly updating a systematic synthesis of evidence to incorporate newly available evidence is known as LE [<xref ref-type="bibr" rid="ref4">4</xref>]. Elliott et al [<xref ref-type="bibr" rid="ref5">5</xref>] developed the basis of the LE model in 2014, which effectively incorporates and summarizes new evidence. The LE synthesis process includes 4 phases: database searching and eligibility assessment, data extraction or collection and risk of bias assessment, synthesis and analysis, and publication update [<xref ref-type="bibr" rid="ref6">6</xref>]. It has also been adapted in areas such as network meta-analysis and guidelines. The onset of COVID-19 increased the incentive to use LE [<xref ref-type="bibr" rid="ref7">7</xref>]. Unlike traditional evidence synthesis, which requires the redeployment of significant resources for updates, the maintenance of an LE synthesis can require more modest resources [<xref ref-type="bibr" rid="ref8">8</xref>]. However, LE synthesis that focuses on evolving topics may have a reduced reliability compared to traditional evidence synthesis. The incorporation of artificial intelligence (AI) techniques has the potential to enhance the reliability of LE synthesis by, for example, leveraging advanced algorithms to continuously assess and filter the most relevant and high-quality evidence [<xref ref-type="bibr" rid="ref9">9</xref>].</p><p>The field of AI, which encompasses machine learning, deep learning, natural language processing, data mining, image recognition, and computer vision, to name a few, has the potential to enhance the efficiency of LE synthesis [<xref ref-type="bibr" rid="ref10">10</xref>,<xref ref-type="bibr" rid="ref11">11</xref>]. In 2013, Adams et al [<xref ref-type="bibr" rid="ref11">11</xref>] indicated that leveraging AI to automate the LE synthesis procedures could simplify the regular updating and maintenance of evidence. The development of AI systems, particularly AI based on large language models (LLMs), such as the generative pretrained transformer, has significantly advanced natural generative language systems [<xref ref-type="bibr" rid="ref12">12</xref>]. Various AI-driven tools have been developed for different phases of LE synthesis, such as crowdsourcing and task-sharing platforms like HDAS [<xref ref-type="bibr" rid="ref13">13</xref>]. However, the performance of the AI techniques and the phases of LE synthesis where AI is used remain unclear.</p><p>Overall, the objectives of this review are (1) to conduct a review analyzing the phases of LE synthesis that use AI and (2) to explore whether AI can improve the efficiency, accuracy, or utility of LE synthesis.</p></sec><sec id="s2" sec-type="methods"><title>Methods</title><p>This is the first version of an LE synthesis. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 statement for living systematic reviews (PRISMA-LSR; <xref ref-type="supplementary-material" rid="app3">Checklist 1</xref>) was used as a guide for reporting this LE synthesis [<xref ref-type="bibr" rid="ref14">14</xref>]. The review has been registered in the Open Science Forum [<xref ref-type="bibr" rid="ref15">15</xref>].</p><sec id="s2-1"><title>Search Strategy</title><p>We systematically searched the Web of Science, PubMed, the Cochrane Library, Epistemonikos, the Campbell Library, IEEE Xplore, medRxiv, COVID-19 Evidence Network to support Decision-making, and McMaster Health Forum for publications up to April 2, 2025. The details of the search strategy used can be found in Table S1 in <xref ref-type="supplementary-material" rid="app1">Multimedia Appendix 1</xref>. We subscribed to the Web of Science, PubMed, the Cochrane Library, the Campbell Library, and IEEE Xplore for monthly dynamic updates and used Covidence to facilitate the screening and extraction processes for maintaining an LE synthesis. We plan to conduct living updates for a 12-month period (from April 2025 to April 2026). The final update is scheduled for April 2, 2026, after which we will assess whether to retire the living mode based on the following established triggers: (1) evidence on &#x201C;the AI application in LE synthesis&#x201D; has reached conclusiveness, (2) the topic no longer holds decision-making value for the field, (3) no new eligible studies emerge during the 12-month update period, or (4) subsequent resource or funding support is unavailable [<xref ref-type="bibr" rid="ref16">16</xref>,<xref ref-type="bibr" rid="ref17">17</xref>].</p></sec><sec id="s2-2"><title>Inclusion and Exclusion Criteria</title><p>First, the LE synthesis includes living systematic review, living meta-analysis, living network meta-analysis, living guideline, living scoping review, living overview, living umbrella review, and living mapping. In this review, the types of included studies were classified into 2 categories based primarily on whether a meta-analysis had been performed. These categories include the LE synthesis (without a meta-analysis) and living meta-analysis (with a meta-analysis conducted).</p><p>Second, the criteria for inclusion in this review are studies that use AI or semiautomated tools in the following phases of LE synthesis: (1) database searching and eligibility assessment, (2) data extraction or collection and risk of bias assessment, (3) synthesis and analysis, or (4) publication update [<xref ref-type="bibr" rid="ref6">6</xref>]. The LE syntheses from any field were included. In addition, studies that developed AI or semiautomated tools for LE synthesis were also included. <xref ref-type="other" rid="box1">Textbox 1</xref> provides further details.</p><boxed-text id="box1"><title> Inclusion and exclusion criteria for the study.</title><p>Inclusion criteria</p><list list-type="bullet"><list-item><p>The studies using artificial intelligence (AI) or semiautomated tools in the following phases of living evidence (LE) synthesis: (1) database searching and eligibility assessment, (2) data extraction or collection and risk of bias assessment, (3) synthesis and analysis, or (4) publication update. A study can be any type of LE synthesis in any field, including but not limited to all scientific journals in the social sciences.</p></list-item><list-item><p>Studies that developed AI or semiautomated tools for LE synthesis.</p></list-item></list><p>Exclusion criteria</p><list list-type="bullet"><list-item><p>Studies that did not document the use of AI or semiautomated tools in LE synthesis.</p></list-item><list-item><p>Protocol, commentaries, editorials, letters to the editor, and updating studies.</p></list-item></list></boxed-text><p>We excluded studies that did not document the use of AI or semiautomated tools in LE synthesis. In addition, protocols, commentaries, editorials, letters to the editor, and updating studies were also excluded, as shown in <xref ref-type="other" rid="box1">Textbox 1</xref>.</p><p>Third, AI tools are characterized by autonomous learning and end-to-end decision-making. They enable the independent execution of data collection, feature extraction, model training, and inference and generate output results without any human intervention. However, semiautomated tools incorporate human review or decision support at critical stages, using a &#x201C;machine assistance and human oversight&#x201D; collaborative paradigm [<xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref>]. <xref ref-type="other" rid="box2">Textbox 2</xref> shows the types of AI or semiautomated tools, where AI or semiautomated tools were categorized by the application phases. First, the first segment of the AI or semiautomated tools for each phase is sourced from Bendersky et al [<xref ref-type="bibr" rid="ref13">13</xref>]. Second, the subsequent segment is derived from the work of Khalil et al [<xref ref-type="bibr" rid="ref20">20</xref>]. Third, for the final segment, AI or semiautomated tools were identified and summarized from relevant studies using a manual search. The AI techniques based on LLMs, such as the generative pretrained transformer, were also included.</p><boxed-text id="box2"><title> Artificial intelligence (AI) or semiautomated tools used in the 4 phases of living evidence (LE) synthesis.</title><p>Phase 1. Database searching and eligibility assessment</p><list list-type="bullet"><list-item><p>Segment 1.1: Automatic, continuous database search with push notification, database aggregators (such as HDAS, Epistemonikos), notification from clinical trial registries, randomized clinical trial classifier, text mining technologies, and automatic retrieval of full-text papers</p></list-item><list-item><p>Segment 1.2: RCT tagger, LitSuggest, Evidence mapping tool, SRA-Polyglot Search Translator, QuickClinical, HDAS, ROBOTsearch, SRA-word, frequency analyzer, The Search Refiner, Sherlock, SRA De-duplicate, Distiller, R package-rev tools, Rayyan, EPPI-reviewer, Abstrackr, SRA helper, LibSVM classifier, Bibot, Active Screener, RobotAnalyst, Swift-Review, Evidence Pipeline, JBI Sumari, EndNote, SARA, eSuRFr, ParsCit, and Citation searcher</p></list-item><list-item><p>Segment 1.3: Natural language processing&#x2013;assisted abstract screening tool, automatic text classifiers supported by deep learning&#x2013;based language models, machine learning classifiers, Cochrane Crowd, Living Interactive Evidence (LIvE) synthesis platform, Cochrane RCT classifier, OpenAlex, Risklick AI, Bayesian classifier, Generative Pretrained Transformer models, and RobotReviewer LIVE</p></list-item></list><p>Phase 2. Data extraction or collection and risk of bias assessment</p><list list-type="bullet"><list-item><p>Segment 2.1: Machine learning information-extraction systems, automated structured data extraction tools for PDFs, machine learning&#x2013;assisted RoB tool, data repositories, and linked data</p></list-item><list-item><p>Segment 2.2: RobotReviewer, DistelleR, JBI Sumari, in-house data extraction tool written in R, statistical package R, ExaCT, Revman, Raptor, ContentMine, Graph2Data, and Evidence mapping tool</p></list-item><list-item><p>Segment 2.3: BioMart, MetaInsight COVID-19, LIvE synthesis platform, Open Science Framework (OSF), PsychOpen CAMA, and Generative Pretrained Transformer models</p></list-item></list><p>Phase 3. Synthesis and analysis</p><list list-type="bullet"><list-item><p>Segment 3.1: Structured data extraction tools, which automatically provide data in a suitable format for statistical analysis; continuous analysis updating based on availability of structured extracted data; and statistical surveillance of key analysis results, with threshold set for potential conclusion change</p></list-item><list-item><p>Segment 3.2: MetaPreg, MetaXL, NetMetaXL, Meta-analyst, Webplotdigitizer, Evidence mapping tool, PRISMA flow diagram generator, Evidence mapping tool, R package-rev tools</p></list-item><list-item><p>Segment 3.3: Risklick AI, Web Source Processing Pipeline, LIvE synthesis platform, and generative pretrained transformer models</p></list-item></list><p>Phase 4. Publication update</p><list list-type="bullet"><list-item><p>Segment 4.1: Templated reporting of some report items, automatic text generation tools for synthesis and writing, automatization in the identification of changes between LSR versions for peer review, and editorial process (such as Archie)</p></list-item><list-item><p>Segment 4.2: Trial2rev, RevManHAL, DistelleR, SRA replicant writer, SRA-RevMan Replicant, and JBI Sumari</p></list-item><list-item><p>Segment 4.3: Generative pretrained transformer models</p></list-item></list></boxed-text></sec><sec id="s2-3"><title>Study Screening and Data Collection</title><p>Two reviewers independently screened the titles and abstracts of all selected studies, followed by a full-text review. Any disagreements regarding selection were resolved by a third researcher. Data were extracted using a predesigned Microsoft Excel sheet. Two reviewers independently extracted data from all included studies, including information such as title, first author, journal, year of publication, LE synthesis type, types of tool or technology, types of AI or semiautomated tools, phases of LE synthesis, outcomes, and so forth. Any disagreements were resolved by a third researcher. During data extraction, representative outcomes (such as means or ranges) were prioritized for synthesis, with the range of values considered subsequently when outcomes were similarly representative.</p></sec><sec id="s2-4"><title>Methodological Quality Assessment</title><p>Given the lack of a standardized tool for assessing the methodological quality of AI-related studies, the 24 studies were categorized into 3 types by methodological characteristics and primary objective (diagnostic test, tool development, or&#x2014;when neither applied&#x2014;a general synthesis) and assessed for methodological quality using the modified version of the Quality Assessment of Diagnostic Accuracy Studies version 2 (QUADAS-2) tool, Joanna Briggs Institute (JBI) Critical Appraisal Checklist for Textual Evidence: Narrative, and AMSTAR 2 tool. First, 10 studies were assessed with the modified version of the QUADAS-2 tool: these studies specifically assessed the application of AI in the database searching and eligibility assessment phase, which aligns with a diagnostic test accuracy (DTA) framework. We adopted the modified version of the QUADAS-2 proposed by Rashid et al [<xref ref-type="bibr" rid="ref21">21</xref>-<xref ref-type="bibr" rid="ref23">23</xref>]. As QUADAS-2 is designed for DTA research contexts, this framework was only applicable to those studies where one of the objectives included the application of AI in the database searching and eligibility assessment phase [<xref ref-type="bibr" rid="ref21">21</xref>,<xref ref-type="bibr" rid="ref24">24</xref>,<xref ref-type="bibr" rid="ref25">25</xref>]. The core elements of QUADAS-2 were revised to adapt it to AI-related research scenarios, as follows: &#x201C;patient&#x201D; was replaced with &#x201C;study,&#x201D; &#x201C;index test&#x201D; with &#x201C;AI,&#x201D; &#x201C;reference standard&#x201D; with &#x201C;comparator,&#x201D; and &#x201C;case-control design&#x201D; with &#x201C;DTA framework.&#x201D; We also constructed a 2&#x00D7;2 table, categorizing studies into &#x201C;included&#x201D; or &#x201C;excluded&#x201D; based on both &#x201C;AI screening results&#x201D; and &#x201C;reference/original systematic review (SR) screening results,&#x201D; with counts denoted as a, b, c, and d, respectively. The details of the modified QUADAS-2 are provided in Table S2 in <xref ref-type="supplementary-material" rid="app1">Multimedia Appendix 1</xref>. Second, 5 studies, which specifically developed AI or semiautomated tools for LE synthesis without DTA-related accuracy evaluation and were not designed as LE synthesis themselves, were assessed using the JBI Critical Appraisal Checklist for Textual Evidence: Narrative [<xref ref-type="bibr" rid="ref26">26</xref>]. Third, 9 studies, which were designed as LE syntheses without DTA-related accuracy evaluation and not primarily focused on AI or semiautomated tool development (or tool development was only an auxiliary means), were assessed using the AMSTAR 2 tool [<xref ref-type="bibr" rid="ref27">27</xref>,<xref ref-type="bibr" rid="ref28">28</xref>]. The details are shown in Tables S3 and S4 in <xref ref-type="supplementary-material" rid="app1">Multimedia Appendix 1</xref>. All of the included studies were evaluated independently by 2 reviewers (RL and ZY), and disagreement was resolved by a third reviewer (ZL). The LE synthesis did not involve a statistical combination of results (meta-analysis), as its aims were to document the phases of LE synthesis where AI is used and to investigate whether AI improves the efficiency, accuracy, or utility of LE synthesis. Therefore, several systematic review procedures&#x2014;including sensitivity analyses, reporting bias assessment, certainty assessment, and investigations of heterogeneity&#x2014;were not used.</p></sec><sec id="s2-5"><title>Data Analysis</title><p>This review conducted 3 complementary analyses, as shown in <xref ref-type="fig" rid="figure1">Figure 1</xref>.</p><fig position="float" id="figure1"><label>Figure 1.</label><caption><p>Road map for the use of artificial intelligence (AI): applications and extractable clinical outcomes across 4 phases of living evidence synthesis. LE: living evidence.</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="jmir_v28i1e76130_fig01.png"/></fig><sec id="s2-5-1"><title>Analysis 1: Phases of LE Synthesis Utilizing AI or Semiautomated Tools</title><p>We analyzed the prevalence and distribution of AI or semiautomated tools across 4 phases of LE synthesis. Phase 1 is database searching and eligibility assessment. This process includes going through the databases, retrieving the results, importing them into the citation management software, removing any duplicate results, and assessing their eligibility individually. Phase 2 is data extraction or collection and risk of bias assessment; once the eligibility of studies has been verified and they have been included in the review process, it becomes crucial to systematically extract and collect information about their main characteristics and results. Additionally, it is very important to assess the risk of bias associated with the conduct and methodology used in the studies. In phase 3&#x2014;synthesis and analysis&#x2014;the data that have been assessed to conform to the criteria are integrated, and the data are analyzed. In phase 4&#x2014;publication update&#x2014;after going through the aforementioned phases 1-3, sections of a review are generated based on their results, and conclusions are updated.</p></sec><sec id="s2-5-2"><title>Analysis 2: AI or Semiautomated Tools Used in LE Synthesis</title><p>First, the types of AI or semiautomated tools applied in each LE synthesis phase were investigated. Second, the frequency of AI or semiautomated tools applied in the LE synthesis was analyzed.</p></sec><sec id="s2-5-3"><title>Analysis 3: Primary Outcomes Investigating AI or Semiautomated Tools in LE Synthesis</title><p>The impact of applied AI or semiautomated tools in LE synthesis was analyzed across 3 outcomes [<xref ref-type="bibr" rid="ref29">29</xref>]. First, efficiency, defined as the relationship between the time required to complete a workload and the workload itself, was evaluated to determine whether either the duration or workload was reduced with the use of AI or semiautomated tools. This outcome may be described as time reduction, workload reduction, and conflict rates with and without the tool.</p><p>Second, accuracy is used to assess performance with and without AI or semiautomated tools. It may be described as accuracy, recall, precision, <italic>F</italic><sub>1</sub>-score, area under the receiver operating characteristic curve, number needed to read, and study relevance. In addition, we calculated the overall mean recall and mean <italic>F</italic><sub>1</sub>-score using the following formula:</p><disp-formula id="equWL1"><mml:math id="eqn1"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mover><mml:mi>M</mml:mi><mml:mrow><mml:mo stretchy="false">ˉ</mml:mo></mml:mrow></mml:mover><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mi>N</mml:mi></mml:mfrac><mml:mtext>&#x00A0;</mml:mtext><mml:munderover><mml:mo movablelimits="false">&#x2211;</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:munderover><mml:msub><mml:mi>M</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mstyle></mml:mstyle></mml:mrow></mml:mstyle></mml:math></disp-formula><p>where <inline-formula><mml:math id="ieqn1"><mml:msub><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the representative value for study <inline-formula><mml:math id="ieqn2"><mml:mi>i</mml:mi></mml:math></inline-formula>, defined as the reported single value, if provided, or the midpoint of the reported range [L, U], calculated as (L+U)/2, if a range was provided. <inline-formula><mml:math id="ieqn3"><mml:mi>N</mml:mi></mml:math></inline-formula> is the number of studies reporting that metric [<xref ref-type="bibr" rid="ref30">30</xref>,<xref ref-type="bibr" rid="ref31">31</xref>].</p><p>Third, utility is used to assess whether user decisions align with those of AI or semiautomated tools, including user consistency, user satisfaction, perceived ease of use, and study quality.</p></sec></sec></sec><sec id="s3" sec-type="results"><title>Results</title><sec id="s3-1"><title>Search Results</title><p>Out of 9180 studies, 24 studies applied AI or semiautomated tools in LE synthesis, including 17 LE syntheses (4 developing tools) and 7 living meta-analyses (3 developing tools), as shown in <xref ref-type="fig" rid="figure2">Figure 2</xref> [<xref ref-type="bibr" rid="ref29">29</xref>,<xref ref-type="bibr" rid="ref32">32</xref>-<xref ref-type="bibr" rid="ref54">54</xref>]. In addition, 8 studies exclusively applied AI tools in LE synthesis, 11 studies exclusively applied semiautomated tools, and 5 studies utilized both AI and semiautomated tools. The basic characteristics of the included studies are shown in Table S5 in <xref ref-type="supplementary-material" rid="app1">Multimedia Appendix 1</xref>. The details of the studies excluded at the full-text eligibility stage with reasons are shown in Table S6 in <xref ref-type="supplementary-material" rid="app1">Multimedia Appendix 1</xref> [<xref ref-type="bibr" rid="ref5">5</xref>,<xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref55">55</xref>-<xref ref-type="bibr" rid="ref75">75</xref>].</p><fig position="float" id="figure2"><label>Figure 2.</label><caption><p>Database search flow diagram. LE: living evidence.</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="jmir_v28i1e76130_fig02.png"/></fig></sec><sec id="s3-2"><title>Methodological Quality of Included Studies</title><p>We conducted a methodological quality assessment of 10 studies using a revised QUADAS-2 tool within the DTA framework [<xref ref-type="bibr" rid="ref29">29</xref>,<xref ref-type="bibr" rid="ref32">32</xref>,<xref ref-type="bibr" rid="ref35">35</xref>,<xref ref-type="bibr" rid="ref36">36</xref>,<xref ref-type="bibr" rid="ref42">42</xref>-<xref ref-type="bibr" rid="ref44">44</xref>,<xref ref-type="bibr" rid="ref51">51</xref>,<xref ref-type="bibr" rid="ref52">52</xref>,<xref ref-type="bibr" rid="ref54">54</xref>]. All studies were assessed as low-risk in the &#x201C;Study selection,&#x201D; &#x201C;Index test (AI),&#x201D; and &#x201C;Reference (comparator)&#x201D; domains. While none of the studies specified the time interval between the task execution of AI and comparator-based analysis, all were determined as low-risk in the &#x201C;Flow and timing&#x201D; domain. Additionally, we did not identify any applicability concerns, as all studies were classified as low-risk in the &#x201C;Applicability&#x201D; domain (<xref ref-type="table" rid="table1">Table 1</xref>). Five studies were subjected to methodological quality assessment using the JBI Critical Appraisal Checklist for Textual Evidence: Narrative [<xref ref-type="bibr" rid="ref41">41</xref>,<xref ref-type="bibr" rid="ref46">46</xref>,<xref ref-type="bibr" rid="ref48">48</xref>-<xref ref-type="bibr" rid="ref50">50</xref>]. Four studies obtained a score of 5/6, with a narrative appraisal of &#x201C;Exclude&#x201D; owing to failure to meet the narrative classification criterion [<xref ref-type="bibr" rid="ref41">41</xref>,<xref ref-type="bibr" rid="ref46">46</xref>,<xref ref-type="bibr" rid="ref48">48</xref>,<xref ref-type="bibr" rid="ref49">49</xref>]. One study achieved a full score of 6/6 and was thus appraised as &#x201C;Include&#x201D; (Table S7 in <xref ref-type="supplementary-material" rid="app1">Multimedia Appendix 1</xref>) [<xref ref-type="bibr" rid="ref50">50</xref>]. In addition, we conducted a methodological quality assessment of 9 studies using AMSTAR 2 [<xref ref-type="bibr" rid="ref33">33</xref>,<xref ref-type="bibr" rid="ref34">34</xref>,<xref ref-type="bibr" rid="ref37">37</xref>-<xref ref-type="bibr" rid="ref40">40</xref>,<xref ref-type="bibr" rid="ref45">45</xref>,<xref ref-type="bibr" rid="ref47">47</xref>,<xref ref-type="bibr" rid="ref53">53</xref>]. The methodological quality scores of the included studies ranged from 11 to 15. Overall, the methodological quality of eight studies [<xref ref-type="bibr" rid="ref34">34</xref>,<xref ref-type="bibr" rid="ref37">37</xref>-<xref ref-type="bibr" rid="ref40">40</xref>,<xref ref-type="bibr" rid="ref45">45</xref>,<xref ref-type="bibr" rid="ref47">47</xref>,<xref ref-type="bibr" rid="ref53">53</xref>] was rated as moderate, while only 1 study [<xref ref-type="bibr" rid="ref33">33</xref>] was rated as low in methodological quality. The most common limitation was that the authors failed to provide a list of excluded studies (Table S8 in <xref ref-type="supplementary-material" rid="app1">Multimedia Appendix 1</xref>).</p><table-wrap id="t1" position="float"><label>Table 1.</label><caption><p>Summary of modified Quality Assessment of Diagnostic Accuracy Studies version 2 (QUADAS-2) assessments for studies using artificial intelligence (AI) or semiautomated tools in the database searching and eligibility phase of the living evidence (LE) synthesis process.</p></caption><table id="table1" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom">Author, year</td><td align="left" valign="bottom" colspan="4">Risk of bias</td><td align="left" valign="bottom" colspan="3">Applicability concern</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Study selection</td><td align="left" valign="bottom">Index test (AI)</td><td align="left" valign="bottom">Reference (comparator)</td><td align="left" valign="bottom">Flow and timing</td><td align="left" valign="bottom">Study selection</td><td align="left" valign="bottom">Index test (AI)</td><td align="left" valign="bottom">Reference (comparator)</td></tr></thead><tbody><tr><td align="left" valign="top">Knafou et al [<xref ref-type="bibr" rid="ref32">32</xref>] (2023)</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td></tr><tr><td align="left" valign="top">Perlman-Arrow et al [<xref ref-type="bibr" rid="ref29">29</xref>] (2023)</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td></tr><tr><td align="left" valign="top">Chou et al [<xref ref-type="bibr" rid="ref35">35</xref>] (2020)</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td></tr><tr><td align="left" valign="top">Kamso et al [<xref ref-type="bibr" rid="ref36">36</xref>] (2023)</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td></tr><tr><td align="left" valign="top">Marshall et al [<xref ref-type="bibr" rid="ref42">42</xref>] (2023)</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td></tr><tr><td align="left" valign="top">Haas et al [<xref ref-type="bibr" rid="ref43">43</xref>] (2021)</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td></tr><tr><td align="left" valign="top">Vaghela et al [<xref ref-type="bibr" rid="ref44">44</xref>] (2021)</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td></tr><tr><td align="left" valign="top">Shemilt et al [<xref ref-type="bibr" rid="ref51">51</xref>] (2024)</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td></tr><tr><td align="left" valign="top">Le-Khac et al [<xref ref-type="bibr" rid="ref52">52</xref>] (2024)</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td></tr><tr><td align="left" valign="top">Hair et al [<xref ref-type="bibr" rid="ref54">54</xref>] (2024)</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td><td align="left" valign="top">Low</td></tr></tbody></table></table-wrap></sec><sec id="s3-3"><title>Types and Frequency of AI or Semiautomated Tools in LE Synthesis</title><p>A total of 34 AI or semiautomated tools were involved, including 12 (35.3%) AI tools and 22 (64.7%) semiautomated tools, as shown in <xref ref-type="supplementary-material" rid="app2">Multimedia Appendix 2</xref>. The most frequently used AI or semiautomated tools were machine learning classifiers (n=5), followed by the Living Interactive Evidence (LIvE) synthesis platform (n=3), AD-SOLES (n=2), Covidence (n=2), and MAGICapp (n=2).</p></sec><sec id="s3-4"><title>Phases of AI or Semiautomated Tools Application in LE Synthesis</title><p>There were 18 AI or semiautomated tools for database searching and eligibility assessment, 20 for data extraction or collection and risk of bias assessment, and 10 for synthesis and analysis. However, only 1 AI tool was used for publication updates. Out of all the tools, RobotReviewer LIVE can be used for all phases of LE synthesis, as shown in <xref ref-type="other" rid="box3">Textbox 3</xref>.</p><boxed-text id="box3"><title> Types of artificial intelligence (AI) or semiautomated tools applications in the 4 phases of living evidence (LE) synthesis.</title><p>Phase 1. Database searching and eligibility assessment</p><list list-type="bullet"><list-item><p>LIvE platform, automatic text classifiers, machine learning ensemble classifier, Natural language processing&#x2013;assisted abstract screening tool, machine learning classifiers, machine learning, PICO annotators, STAR tool, AD-SOLES, Covidence, rcrossref, openalexR, RISmed, RobotReviewer LIVE, Risklick AI, metaCOVID application, supervised text classification models, and text mining techniques</p></list-item></list><p>Phase 2. Data extraction or collection and risk of bias assessment</p><list list-type="bullet"><list-item><p>LIvE platform, web-based interactive app, open-source living systematic review application, Covidence, AD-SOLES, Google Refine tool, script, REDASA, RobotReviewer LIVE, Risklick AI, Metainsight COVID-19, metaCOVID application, information extraction techniques, EndNote, semiautomated model, supervised text classification models, text mining techniques, GPT-4-turbo, Claude-3-Opus, and EPPI-Reviewer</p></list-item></list><p>Phase 3. Synthesis and analysis</p><list list-type="bullet"><list-item><p>LIvE platform, MAGICapp, Trial sequential analysis (TSA) software, AD-SOLES, ODDPub, RobotReviewer LIVE, script, Metainsight COVID-19, metaCOVID application, and Dynameta</p></list-item></list><p>Phase 4. Publication update</p><list list-type="bullet"><list-item><p>RobotReviewer LIVE</p></list-item></list></boxed-text></sec><sec id="s3-5"><title>Impact of AI or Semiautomated Tools on LE Synthesis</title><sec id="s3-5-1"><title>Overview</title><p>A total of 10 (41.7%) studies reported on the impact of AI or semiautomated tools on LE synthesis in terms of efficiency, accuracy, or utility in the database searching and eligibility phase or the data extraction or collection and risk of bias assessment phase. <xref ref-type="table" rid="table2">Table 2</xref> provides a description of the outcome metrics in the included studies.</p><table-wrap id="t2" position="float"><label>Table 2.</label><caption><p>Summary of the indicator terms for outcome metrics in the included studies.</p></caption><table id="table2" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom">Metrics</td><td align="left" valign="bottom">Explanation</td></tr></thead><tbody><tr><td align="left" valign="top" colspan="2">Efficiency</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Time</td><td align="left" valign="top">AI<sup><xref ref-type="table-fn" rid="table2fn1">a</xref></sup> or semiautomated tools were used to save time. Only 2 (8.3%) studies reported on time saving [<xref ref-type="bibr" rid="ref29">29</xref>,<xref ref-type="bibr" rid="ref35">35</xref>]. Specifically, Perlman-Arrow et al [<xref ref-type="bibr" rid="ref29">29</xref>] reported a 45.9% reduction in screening time per abstract in the database searching and eligibility phase. Chou et al [<xref ref-type="bibr" rid="ref35">35</xref>] estimated the time saving ranged from 2.0 to 13.2 hours in the database searching and eligibility phase.</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Workload</td><td align="left" valign="top">Two (8.3%) studies reported on workload metrics related to the use of AI or semiautomated tools [<xref ref-type="bibr" rid="ref29">29</xref>,<xref ref-type="bibr" rid="ref42">42</xref>]. Perlman-Arrow et al [<xref ref-type="bibr" rid="ref29">29</xref>] reported that the semiautomated tool completed 68% of the workload in the database searching and eligibility phase. Marshall et al [<xref ref-type="bibr" rid="ref42">42</xref>] found that manual screening had an efficiency rate of 23% in obtaining 31 abstracts, whereas AI achieved a rate of 55%, demonstrating an efficiency improvement of approximately 140% in the database searching and eligibility phase.</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Conflict rates with and without the tool</td><td align="left" valign="top">The efficiency of abstract screening decreases as the number of conflicting votes increases [<xref ref-type="bibr" rid="ref29">29</xref>]. Perlman-Arrow et al [<xref ref-type="bibr" rid="ref29">29</xref>] reported a reduction in conflict rates from 8.32% to 3.64% with the use of semiautomated tool in the database searching and eligibility phase.</td></tr><tr><td align="left" valign="top" colspan="2">Accuracy<sup><xref ref-type="table-fn" rid="table2fn2">b</xref></sup></td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Precision</td><td align="left" valign="top">Precision refers to the ratio of accurately categorized documents among all the documents that the model assigns to a particular class [<xref ref-type="bibr" rid="ref32">32</xref>]. Eight (33.3%) studies reported on precision [<xref ref-type="bibr" rid="ref29">29</xref>,<xref ref-type="bibr" rid="ref32">32</xref>,<xref ref-type="bibr" rid="ref35">35</xref>,<xref ref-type="bibr" rid="ref42">42</xref>,<xref ref-type="bibr" rid="ref43">43</xref>,<xref ref-type="bibr" rid="ref51">51</xref>,<xref ref-type="bibr" rid="ref53">53</xref>,<xref ref-type="bibr" rid="ref54">54</xref>].<list list-type="order"><list-item><p>Khan et al [<xref ref-type="bibr" rid="ref53">53</xref>] reported a precision rate of even 100% using AI in the data extraction or collection and risk of bias assessment phase.</p></list-item><list-item><p>Perlman-Arrow et al [<xref ref-type="bibr" rid="ref29">29</xref>] and Haas et al [<xref ref-type="bibr" rid="ref43">43</xref>] reported precision rates of 92.10% and 96.07%, respectively, using AI or semiautomated tools in the database searching and eligibility phase.</p></list-item><list-item><p>Hair et al [<xref ref-type="bibr" rid="ref54">54</xref>] reported that the average precision rate using AI is about 84.5% in the database searching and eligibility phase.</p></list-item><list-item><p>Shemilt et al [<xref ref-type="bibr" rid="ref51">51</xref>] reported a precision rate of 50%&#x2010;86% using AI in the database searching and eligibility phase.</p></list-item><list-item><p>Marshall et al [<xref ref-type="bibr" rid="ref42">42</xref>] reported a precision rate of 55% using AI in the database searching and eligibility phase.</p></list-item><list-item><p>Knafou et al [<xref ref-type="bibr" rid="ref32">32</xref>] reported a precision rate of only 29.69% using AI in the database searching and eligibility phase.</p></list-item><list-item><p>However, Chou et al [<xref ref-type="bibr" rid="ref35">35</xref>] reported a precision rate of only 0.2%&#x2010;8% using AI in the database searching and eligibility phase.</p></list-item></list></td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Recall<sup><xref ref-type="table-fn" rid="table2fn3">c</xref></sup></td><td align="left" valign="top">Recall (also known as sensitivity) refers to the fraction of positive documents that have been accurately identified among all documents for the specified class [<xref ref-type="bibr" rid="ref32">32</xref>]. Nine (37.5%) studies reported on recall [<xref ref-type="bibr" rid="ref29">29</xref>,<xref ref-type="bibr" rid="ref32">32</xref>,<xref ref-type="bibr" rid="ref35">35</xref>,<xref ref-type="bibr" rid="ref36">36</xref>,<xref ref-type="bibr" rid="ref42">42</xref>,<xref ref-type="bibr" rid="ref43">43</xref>,<xref ref-type="bibr" rid="ref51">51</xref>,<xref ref-type="bibr" rid="ref53">53</xref>,<xref ref-type="bibr" rid="ref54">54</xref>]. All studies reported recall rates in excess of 87%. The average value was about 96.24%.<list list-type="order"><list-item><p>Perlman-Arrow et al [<xref ref-type="bibr" rid="ref29">29</xref>], Chou et al [<xref ref-type="bibr" rid="ref35">35</xref>], and Marshall et al [<xref ref-type="bibr" rid="ref42">42</xref>] found recall rates of even 100% using AI or semiautomated tools in the database searching and eligibility phase.</p></list-item><list-item><p>Knafou et al [<xref ref-type="bibr" rid="ref32">32</xref>], Haas et al [<xref ref-type="bibr" rid="ref43">43</xref>], and Kamso et al [<xref ref-type="bibr" rid="ref36">36</xref>] reported a recall rate of 89%, 99.25% and 99.3%, respectively, using AI in the database searching and eligibility phase.</p></list-item><list-item><p>Shemilt et al [<xref ref-type="bibr" rid="ref51">51</xref>] reported a recall rate of 94%&#x2010;99% using AI in the database searching and eligibility phase.</p></list-item><list-item><p>Khan et al [<xref ref-type="bibr" rid="ref53">53</xref>] reported a recall rate of 92%&#x2010;96% using AI in the data extraction or collection and risk of bias assessment phase.</p></list-item><list-item><p>Hair et al [<xref ref-type="bibr" rid="ref54">54</xref>] reported that the average sensitivity rate using AI is about 95.1% in the database searching and eligibility phase.</p></list-item></list></td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><italic>F</italic><sub>1</sub>-score<sup><xref ref-type="table-fn" rid="table2fn3">c</xref></sup></td><td align="left" valign="top"><italic>F</italic><sub>1</sub>-score refers to the balanced harmonic average between the model precision and recall [<xref ref-type="bibr" rid="ref32">32</xref>]. Six (25%) studies reported on <italic>F</italic><sub>1</sub>-score [<xref ref-type="bibr" rid="ref29">29</xref>,<xref ref-type="bibr" rid="ref32">32</xref>,<xref ref-type="bibr" rid="ref43">43</xref>,<xref ref-type="bibr" rid="ref52">52</xref>-<xref ref-type="bibr" rid="ref54">54</xref>]. All studies reported <italic>F</italic><sub>1</sub>-score between 80.47% and 99% after using AI. The average value was about 92.17%.<list list-type="order"><list-item><p>Knafou et al [<xref ref-type="bibr" rid="ref32">32</xref>], Perlman-Arrow et al [<xref ref-type="bibr" rid="ref29">29</xref>], and Haas et al [<xref ref-type="bibr" rid="ref43">43</xref>] reported an <italic>F</italic><sub>1</sub>-score of 89.2%, 92.6%, and 97.59%, respectively, using AI or semiautomated tools in the database searching and eligibility phase.</p></list-item><list-item><p>Le-Khac et al [<xref ref-type="bibr" rid="ref52">52</xref>] reported an <italic>F</italic><sub>1</sub>-score of 87% using AI in the data extraction or collection and risk of bias assessment phase.</p></list-item><list-item><p>Khan et al [<xref ref-type="bibr" rid="ref53">53</xref>] reported <italic>F</italic><sub>1</sub>-scores between 96% and 98% after using AI in the data extraction or collection and risk of bias assessment phase.</p></list-item><list-item><p>Hair et al [<xref ref-type="bibr" rid="ref54">54</xref>] reported that the average <italic>F</italic><sub>1</sub>-score using AI is about 89.6% in the database searching and eligibility phase.</p></list-item></list></td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Area under the receiver operating characteristic curve (AUC-ROC)</td><td align="left" valign="top">AUC-ROC calculates the area under the curve between the true positive rate and the false positive rate [<xref ref-type="bibr" rid="ref32">32</xref>]. Knafou et al [<xref ref-type="bibr" rid="ref32">32</xref>] reported higher AUC-ROC performance using AI in the database searching and eligibility phase and had an AUC-ROC performance of 94.25%&#x2010;94.77%.</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Number needed to read (NNR)</td><td align="left" valign="top">NNR refers to the total number of literature considered within the search divided by the number of literature included from the search [<xref ref-type="bibr" rid="ref35">35</xref>]. Only 2 (8.3%) studies reported on NNR [<xref ref-type="bibr" rid="ref29">29</xref>,<xref ref-type="bibr" rid="ref35">35</xref>]. Perlman-Arrow et al [<xref ref-type="bibr" rid="ref29">29</xref>] reported an NNR between 1.086 and 1.125 after using a semiautomated tool in the database searching and eligibility phase. Chou et al [<xref ref-type="bibr" rid="ref35">35</xref>] reported an NNR between 15 and 100 after using AI in the database searching and eligibility phase.</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Article relevance</td><td align="left" valign="top">Vaghela et al [<xref ref-type="bibr" rid="ref44">44</xref>] reported on studies included after searching using AI, and 50.49% were considered relevant to the query in the database searching and eligibility phase.</td></tr><tr><td align="left" valign="top" colspan="2">Utility</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>User satisfaction</td><td align="left" valign="top">Perlman-Arrow et al [<xref ref-type="bibr" rid="ref29">29</xref>] reported that the average satisfaction of users with the tool reached 4.2/5 in the database searching and eligibility phase.</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Consistency</td><td align="left" valign="top">Kamso et al [<xref ref-type="bibr" rid="ref36">36</xref>] reported that consistency in the use of AI between 2 reviewers was assessed using percentage agreement and Kappa scores, revealing a range of percentage agreement from 79.0% to 96.0%, and a variation in Kappa scores from moderate (0.40) to substantial (0.63) in the database searching and eligibility phase.</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Article quality</td><td align="left" valign="top">Vaghela et al [<xref ref-type="bibr" rid="ref44">44</xref>] reported that 64.53% of the included studies possess reliable quality in the database searching and eligibility phase.</td></tr></tbody></table><table-wrap-foot><fn id="table2fn1"><p><sup>a</sup>AI: artificial intelligence.</p></fn><fn id="table2fn2"><p><sup>b</sup>Kamso et al [<xref ref-type="bibr" rid="ref36">36</xref>] achieved an accuracy ranging from 75.9% to 96.9% in research classification using AI in the database searching and eligibility phase. Khan et al [<xref ref-type="bibr" rid="ref53">53</xref>] reported that the collaborative large language models&#x2019; accuracy, based on concordant responses in the prompt set, reached 99% in the data extraction or collection and risk of bias assessment phase.</p></fn><fn id="table2fn3"><p><sup>c</sup>The overall mean recall (96.24%) and <italic>F</italic><sub>1</sub>-score (92.17%) are the simple averages of study&#x2011;level values from Table S5 in <xref ref-type="supplementary-material" rid="app1">Multimedia Appendix 1</xref>. For studies reporting a range, the midpoint was used as the study&#x2011;level value.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3-5-2"><title>Efficiency Enhancements Through AI or Semiautomated Tools in LE Synthesis</title><p>Three studies showed improved efficiency in the database searching and eligibility phase in terms of 3 indicator terms. A total of 2 (8.3%) studies [<xref ref-type="bibr" rid="ref29">29</xref>,<xref ref-type="bibr" rid="ref35">35</xref>] reported on time saving with AI or semiautomated tools, 2 (8.3%) studies [<xref ref-type="bibr" rid="ref29">29</xref>,<xref ref-type="bibr" rid="ref42">42</xref>] reported on workload metrics related to the use of AI or semiautomated tools, and 1 study [<xref ref-type="bibr" rid="ref29">29</xref>] reported a reduction in conflict rates with the use of semiautomated tool, which consequently increases the efficiency.</p></sec><sec id="s3-5-3"><title>Accuracy Improvements With AI or Semiautomated Tools in LE Synthesis</title><p>A total of 9 and 6 studies that applied AI or semiautomated tools in LE synthesis reported a mean recall rate and a mean <italic>F</italic><sub>1</sub>-score of 96.24% and 92.17%, respectively. While Khan et al [<xref ref-type="bibr" rid="ref53">53</xref>] reported a precision rate of even 100% achieved using AI in the data extraction or collection and risk of bias assessment phase. However, in 7 studies, the reported precision rates varied significantly, ranging from 0.2% to 96.07% in the database searching and eligibility phase.</p></sec><sec id="s3-5-4"><title>Utility of AI or Semiautomated Tools in LE Synthesis</title><p>Three studies reported on the utility of AI or semiautomated tools in the database searching and eligibility phase of LE synthesis, including user satisfaction, consistency, and study quality. Consistency in the use of AI between 2 reviewers was assessed using percentage agreement and Kappa scores [<xref ref-type="bibr" rid="ref36">36</xref>].</p></sec></sec></sec><sec id="s4" sec-type="discussion"><title>Discussion</title><sec id="s4-1"><title>Principal Findings</title><p>AI or semiautomated tools are actively used to facilitate the process of LE synthesis. We conducted this review to identify the phases of LE synthesis that use AI and explore whether AI can improve the efficiency, accuracy, or utility of LE synthesis.</p><p>AI or semiautomated tools have been increasingly used in LE synthesis, particularly in living systematic review. This review discovered that AI or semiautomated tools are most commonly used for data extraction or collection and risk of bias assessment. However, only a few studies have addressed the use of AI or semiautomated systems for publication updates, highlighting the need for further development in this phase.</p><p>Diverse types of AI or semiautomated tools were identified in this study. These include the LIvE synthesis platform, AD-SOLES, metaCOVID application, and RobotReviewer LIVE, which are utilized in multiple phases of LE synthesis, indicating their versatility and potential for wider adoption [<xref ref-type="bibr" rid="ref37">37</xref>,<xref ref-type="bibr" rid="ref39">39</xref>,<xref ref-type="bibr" rid="ref40">40</xref>,<xref ref-type="bibr" rid="ref42">42</xref>,<xref ref-type="bibr" rid="ref47">47</xref>,<xref ref-type="bibr" rid="ref54">54</xref>]. The most frequently used AI or semiautomated tools were machine learning classifiers, the LIvE synthesis platform, Covidence, AD-SOLES, and MAGICapp. Furthermore, the rapid rise of AI tools involving LLM types, such as GPT-4-turbo and Claude-3-Opus, has led to their use in LE synthesis. These tools can be suitable for application in multiple or even all phases of LE synthesis, especially in the publication update phase. The application of LLMs to further enhance the efficiency, accuracy, and utility of LE synthesis remains a key focus for researchers and practitioners.</p><p>Governments worldwide, particularly those in leading AI nations such as China, the United States, Germany, the United Kingdom, France, and Canada, are especially emphasizing the transformative impact of AI on research and decision-making processes [<xref ref-type="bibr" rid="ref76">76</xref>,<xref ref-type="bibr" rid="ref77">77</xref>]. Funding from various sources, including the Economic and Social Research Council, reflects a strong financial commitment to advancing AI technologies in evidence synthesis. Furthermore, a growing number of AI guidance and organizations are emerging to embrace the opportunity that AI has taken in producing LE synthesis. For example, Responsible AI in Evidence SynthEsis has provided recommendations for the main roles of responsible AI in the evidence synthesis ecosystem that are involved in responsible AI use [<xref ref-type="bibr" rid="ref78">78</xref>]. Furthermore, organizations such as ALIVE aim to improve societal outcomes by producing and utilizing timely, trustworthy, and affordable evidence.</p><p>Challenges remain in the application of AI in LE synthesis. Machine learning classifiers suffer from low precision and varying efficiency across different topics [<xref ref-type="bibr" rid="ref35">35</xref>]. As an example, RobotReviewer LIVE faces challenges in performance variability for complex reviews, limited study types, and data source constraints [<xref ref-type="bibr" rid="ref42">42</xref>]. Therefore, further research aimed at enhancing the adaptability and stability of AI across various research areas is urgently needed. In addition, ethical issues, data protection measures, and transparency in AI-driven LE synthesis are also key challenges that need to be addressed [<xref ref-type="bibr" rid="ref79">79</xref>]. At the ethical level, AI is prone to selection bias due to the skewness of its training data, which impairs the inclusivity of evidence, and the mechanism of responsibility attribution remains unclear [<xref ref-type="bibr" rid="ref80">80</xref>]. Data protection is another area that faces challenges, as research data required for AI training often contain sensitive information, and existing anonymization technologies cannot fully avoid the risk of privacy breaches [<xref ref-type="bibr" rid="ref81">81</xref>]. Cost considerations in the implementation of AI tools, including initial investment, ongoing operational costs, training expenses, and requirements for hardware and software resources also constitute a significant issue [<xref ref-type="bibr" rid="ref82">82</xref>].</p><p>Policymaking involves judgment, making it more of an art than a science, whereas science is primarily driven by evidence and shapes evidence-informed policymaking [<xref ref-type="bibr" rid="ref83">83</xref>]. Study has indicated that relying solely on systematic reviews for policymaking is far from sufficient; instead, policymakers need to obtain a more diverse range of synthesized evidence to underpin decision-making [<xref ref-type="bibr" rid="ref84">84</xref>]. The LE synthesis, especially by incorporating AI into evidence production, can deliver updated evidence to facilitate evidence-informed policymaking. AI could revolutionize policymaking by facilitating ongoing assessments, ensuring that the policies remain aligned with the latest evidence and evolve in response to new information as it emerges [<xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref5">5</xref>,<xref ref-type="bibr" rid="ref85">85</xref>]. Furthermore, AI enables policymakers to continuously monitor and assess policies throughout their lifecycle, which allows adaptation to shifting circumstances and evolving societal needs in real time [<xref ref-type="bibr" rid="ref86">86</xref>]. Furthermore, the advancement of AI capabilities, particularly through LLMs, adds a deeper analytical layer; LLMs can provide nuanced insights and help predict future research directions relevant to policymaking [<xref ref-type="bibr" rid="ref87">87</xref>]. The application of AI in LE synthesis could transform policy decision-making, advancing policy formulation for policymakers.</p><p>Recent advances in AI provide researchers with new transformative capabilities [<xref ref-type="bibr" rid="ref79">79</xref>]. Van Dijk et al [<xref ref-type="bibr" rid="ref88">88</xref>] indicated that AI tools are a promising innovation in the current practice of systematic evaluation, and researchers have reported positive experiences with these tools. The use of AI enhances efficiency by significantly reducing researchers&#x2019; time and workload [<xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref89">89</xref>]. Manion et al [<xref ref-type="bibr" rid="ref90">90</xref>] indicated that natural language processing could enhance accuracy and reduce errors through a &#x201C;human-in-the-loop&#x201D; approach. The application of AI in LE synthesis has considerably benefited researchers, significantly enhancing their research capabilities.</p><p>This LE synthesis will retain its living mode beyond the present publication, consistent with the methodology. This decision is based on two key considerations: (1) the predefined retirement triggers have not been triggered and (2) the Safe and Responsible Use of AI Working Group (Working Group 3) and the Methods &#x0026; Process Innovation Working Group (Working Group 4) of the Evidence Synthesis Infrastructure Collaborative will benefit from the continuous updates from this LE synthesis to support their future research initiatives [<xref ref-type="bibr" rid="ref91">91</xref>-<xref ref-type="bibr" rid="ref94">94</xref>].</p></sec><sec id="s4-2"><title>Future Research Directions</title><p>In the above discussion, we have suggested the advancement of future work across multiple dimensions. From a technical point of view, efforts are needed to address limitations of existing AI tools, such as inadequate precision and poor adaptability, while deepening research into the LLM applications in the publication update phase of LE synthesis. In the realm of ethics and data governance, it is essential to establish responsibility attribution mechanisms and cross-regulatory data governance frameworks, as well as enhance evidence inclusivity and mitigate privacy risks through algorithmic optimization. Methodologically, we recommend the establishment of a standardized evaluation system for AI applications and refining research design and quality assessment protocols to strengthen the evidence base.</p></sec><sec id="s4-3"><title>Strengths and Limitations</title><p>The strengths of this review include the following: (1) it systematically analyzes the types of AI and semiautomated tools used across the 4 phases of LE synthesis and (2) it provides insights into the opportunities and challenges of using AI or semiautomated tools in LE synthesis regarding efficiency, accuracy, and utility. However, this review still has a few limitations. First, study screening was based on whether the studies reported on the tools used in LE synthesis. Second, studies that did not document the use of AI or semiautomated tools in LE synthesis were excluded from this review, which may introduce bias. Third, the focus of our search strategy on &#x201C;living evidence&#x201D; terminology may have excluded studies describing AI tools for review updates that used different terminology.</p></sec><sec id="s4-4"><title>Conclusion</title><p>Researchers are actively utilizing various AI and semiautomated tools in LE synthesis, primarily for data extraction or collection and risk of bias assessment, while their application in updating publications remains limited. The use of AI or semiautomated tools in LE synthesis improves efficiency in the database searching and eligibility phase and accuracy in the database searching and eligibility phase, as well as in the data extraction or collection and risk of bias assessment phase. The AI or semiautomated tools demonstrate high accuracy, recall, and <italic>F</italic><sub>1</sub>-scores, while precision varies across tools. AI or semiautomated tools also demonstrate good performance in terms of utility in the database searching and eligibility phase.</p></sec></sec></body><back><notes><sec><title>Funding</title><p>This work was supported by the Fundamental Research Funds for the Central Universities (lzujbky-2025&#x2010;15) and Gansu Provincial Center for Disease Control and Prevention Research Program (GSJKKY2025-02).</p></sec><sec><title>Data Availability</title><p>All data generated or analyzed during this study are included in this published article and its supplementary information files.</p></sec></notes><fn-group><fn fn-type="con"><p>XS designed the study, analyzed the data, and drafted the manuscript. ZL designed the study, analyzed the data, drafted the manuscript, and evaluated the quality of included studies. RW, QW, and XL developed the research design. RL and ZY drafted the manuscript and evaluated the quality of the included studies. LF, ZM, and ZP were in charge of data curation. CL, LG, YC, KY, and JL critically reviewed and revised the manuscript. All authors critically revised the study for important intellectual content and approved the final version of the manuscript.</p></fn><fn fn-type="conflict"><p>None declared.</p></fn></fn-group><glossary><title>Abbreviations</title><def-list><def-item><term id="abb1">AI</term><def><p>artificial intelligence</p></def></def-item><def-item><term id="abb2">DTA</term><def><p>diagnostic test accuracy</p></def></def-item><def-item><term id="abb3">JBI</term><def><p>Joanna Briggs Institute</p></def></def-item><def-item><term id="abb4">LE</term><def><p>living evidence</p></def></def-item><def-item><term id="abb5">LIvE</term><def><p>Living Interactive Evidence</p></def></def-item><def-item><term id="abb6">LLM</term><def><p>large language model</p></def></def-item><def-item><term id="abb7">PRISMA-LSR </term><def><p>Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 statement for living systematic reviews</p></def></def-item><def-item><term id="abb8">QUADAS-2</term><def><p>Quality Assessment of Diagnostic Accuracy Studies version 2</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="ref1"><label>1</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elliott</surname><given-names>J</given-names> </name><name name-style="western"><surname>Lawrence</surname><given-names>R</given-names> </name><name name-style="western"><surname>Minx</surname><given-names>JC</given-names> </name><etal/></person-group><article-title>Decision makers need constantly updated evidence synthesis</article-title><source>Nature</source><year>2021</year><month>12</month><volume>600</volume><issue>7889</issue><fpage>383</fpage><lpage>385</lpage><pub-id pub-id-type="doi">10.1038/d41586-021-03690-1</pub-id><pub-id pub-id-type="medline">34912079</pub-id></nlm-citation></ref><ref id="ref2"><label>2</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sampson</surname><given-names>M</given-names> </name><name name-style="western"><surname>Shojania</surname><given-names>KG</given-names> </name><name name-style="western"><surname>Garritty</surname><given-names>C</given-names> </name><name name-style="western"><surname>Horsley</surname><given-names>T</given-names> </name><name name-style="western"><surname>Ocampo</surname><given-names>M</given-names> </name><name name-style="western"><surname>Moher</surname><given-names>D</given-names> </name></person-group><article-title>Systematic reviews can be produced and published faster</article-title><source>J Clin Epidemiol</source><year>2008</year><month>06</month><volume>61</volume><issue>6</issue><fpage>531</fpage><lpage>536</lpage><pub-id pub-id-type="doi">10.1016/j.jclinepi.2008.02.004</pub-id><pub-id pub-id-type="medline">18471656</pub-id></nlm-citation></ref><ref id="ref3"><label>3</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shojania</surname><given-names>KG</given-names> </name><name name-style="western"><surname>Sampson</surname><given-names>M</given-names> </name><name name-style="western"><surname>Ansari</surname><given-names>MT</given-names> </name><name name-style="western"><surname>Ji</surname><given-names>J</given-names> </name><name name-style="western"><surname>Doucette</surname><given-names>S</given-names> </name><name name-style="western"><surname>Moher</surname><given-names>D</given-names> </name></person-group><article-title>How quickly do systematic reviews go out of date? A survival analysis</article-title><source>Ann Intern Med</source><year>2007</year><month>08</month><day>21</day><volume>147</volume><issue>4</issue><fpage>224</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-147-4-200708210-00179</pub-id><pub-id pub-id-type="medline">17638714</pub-id></nlm-citation></ref><ref id="ref4"><label>4</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Turner</surname><given-names>T</given-names> </name><name name-style="western"><surname>Lavis</surname><given-names>JN</given-names> </name><name name-style="western"><surname>Grimshaw</surname><given-names>JM</given-names> </name><name name-style="western"><surname>Green</surname><given-names>S</given-names> </name><name name-style="western"><surname>Elliott</surname><given-names>J</given-names> </name></person-group><article-title>Living evidence and adaptive policy: perfect partners?</article-title><source>Health Res Policy Syst</source><year>2023</year><month>12</month><day>18</day><volume>21</volume><issue>1</issue><fpage>135</fpage><pub-id pub-id-type="doi">10.1186/s12961-023-01085-4</pub-id><pub-id pub-id-type="medline">38111030</pub-id></nlm-citation></ref><ref id="ref5"><label>5</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elliott</surname><given-names>JH</given-names> </name><name name-style="western"><surname>Turner</surname><given-names>T</given-names> </name><name name-style="western"><surname>Clavisi</surname><given-names>O</given-names> </name><etal/></person-group><article-title>Living systematic reviews: an emerging opportunity to narrow the evidence-practice gap</article-title><source>PLoS Med</source><year>2014</year><month>02</month><volume>11</volume><issue>2</issue><fpage>e1001603</fpage><pub-id pub-id-type="doi">10.1371/journal.pmed.1001603</pub-id><pub-id pub-id-type="medline">24558353</pub-id></nlm-citation></ref><ref id="ref6"><label>6</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomas</surname><given-names>J</given-names> </name><name name-style="western"><surname>Noel-Storr</surname><given-names>A</given-names> </name><name name-style="western"><surname>Marshall</surname><given-names>I</given-names> </name><etal/></person-group><article-title>Living systematic reviews: 2. Combining human and machine effort</article-title><source>J Clin Epidemiol</source><year>2017</year><month>11</month><volume>91</volume><fpage>31</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/j.jclinepi.2017.08.011</pub-id><pub-id pub-id-type="medline">28912003</pub-id></nlm-citation></ref><ref id="ref7"><label>7</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tendal</surname><given-names>B</given-names> </name><name name-style="western"><surname>Vogel</surname><given-names>JP</given-names> </name><name name-style="western"><surname>McDonald</surname><given-names>S</given-names> </name><etal/></person-group><article-title>Weekly updates of national living evidence-based guidelines: methods for the Australian living guidelines for care of people with COVID-19</article-title><source>J Clin Epidemiol</source><year>2021</year><month>03</month><volume>131</volume><fpage>11</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1016/j.jclinepi.2020.11.005</pub-id><pub-id pub-id-type="medline">33188858</pub-id></nlm-citation></ref><ref id="ref8"><label>8</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elliott</surname><given-names>JH</given-names> </name><name name-style="western"><surname>Synnot</surname><given-names>A</given-names> </name><name name-style="western"><surname>Turner</surname><given-names>T</given-names> </name><etal/></person-group><article-title>Living systematic review: 1. Introduction-the why, what, when, and how</article-title><source>J Clin Epidemiol</source><year>2017</year><month>11</month><volume>91</volume><fpage>23</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1016/j.jclinepi.2017.08.010</pub-id><pub-id pub-id-type="medline">28912002</pub-id></nlm-citation></ref><ref id="ref9"><label>9</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schmidt</surname><given-names>L</given-names> </name><name name-style="western"><surname>Sinyor</surname><given-names>M</given-names> </name><name name-style="western"><surname>Webb</surname><given-names>RT</given-names> </name><etal/></person-group><article-title>A narrative review of recent tools and innovations toward automating living systematic reviews and evidence syntheses</article-title><source>Z Evid Fortbild Qual Gesundhwes</source><year>2023</year><month>09</month><volume>181</volume><fpage>65</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1016/j.zefq.2023.06.007</pub-id><pub-id pub-id-type="medline">37596160</pub-id></nlm-citation></ref><ref id="ref10"><label>10</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>Y</given-names> </name><name name-style="western"><surname>Qin</surname><given-names>J</given-names> </name><name name-style="western"><surname>Lei</surname><given-names>J</given-names> </name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names> </name></person-group><article-title>Research status and challenges on the sustainable development of artificial intelligence courses from a global perspective</article-title><source>Sustainability</source><year>2023</year><volume>15</volume><issue>12</issue><fpage>9335</fpage><pub-id pub-id-type="doi">10.3390/su15129335</pub-id></nlm-citation></ref><ref id="ref11"><label>11</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adams</surname><given-names>CE</given-names> </name><name name-style="western"><surname>Polzmacher</surname><given-names>S</given-names> </name><name name-style="western"><surname>Wolff</surname><given-names>A</given-names> </name></person-group><article-title>Systematic reviews: work that needs to be done and not to be done</article-title><source>J Evid Based Med</source><year>2013</year><month>11</month><volume>6</volume><issue>4</issue><fpage>232</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1111/jebm.12072</pub-id><pub-id pub-id-type="medline">24325416</pub-id></nlm-citation></ref><ref id="ref12"><label>12</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Su&#x00E1;rez</surname><given-names>A</given-names> </name><name name-style="western"><surname>Jim&#x00E9;nez</surname><given-names>J</given-names> </name><name name-style="western"><surname>Llorente de Pedro</surname><given-names>M</given-names> </name><etal/></person-group><article-title>Beyond the scalpel: assessing ChatGPT&#x2019;s potential as an auxiliary intelligent virtual assistant in oral surgery</article-title><source>Comput Struct Biotechnol J</source><year>2024</year><month>12</month><volume>24</volume><fpage>46</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1016/j.csbj.2023.11.058</pub-id><pub-id pub-id-type="medline">38162955</pub-id></nlm-citation></ref><ref id="ref13"><label>13</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bendersky</surname><given-names>J</given-names> </name><name name-style="western"><surname>Auladell-Rispau</surname><given-names>A</given-names> </name><name name-style="western"><surname>Urr&#x00FA;tia</surname><given-names>G</given-names> </name><name name-style="western"><surname>Rojas-Reyes</surname><given-names>MX</given-names> </name></person-group><article-title>Methods for developing and reporting living evidence synthesis</article-title><source>J Clin Epidemiol</source><year>2022</year><month>12</month><volume>152</volume><fpage>89</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1016/j.jclinepi.2022.09.020</pub-id><pub-id pub-id-type="medline">36220626</pub-id></nlm-citation></ref><ref id="ref14"><label>14</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Akl</surname><given-names>EA</given-names> </name><name name-style="western"><surname>Khabsa</surname><given-names>J</given-names> </name><name name-style="western"><surname>Iannizzi</surname><given-names>C</given-names> </name><etal/></person-group><article-title>Extension of the PRISMA 2020 statement for living systematic reviews (PRISMA-LSR): checklist and explanation</article-title><source>BMJ</source><year>2024</year><month>11</month><day>19</day><volume>387</volume><fpage>e079183</fpage><pub-id pub-id-type="doi">10.1136/bmj-2024-079183</pub-id><pub-id pub-id-type="medline">39562017</pub-id></nlm-citation></ref><ref id="ref15"><label>15</label><nlm-citation citation-type="web"><article-title>Which phases of living evidence synthesis use artificial intelligence (AI)? an living evidence synthesis</article-title><source>OSF</source><access-date>2026-01-16</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.17605/OSF.IO/4FVDQ">https://doi.org/10.17605/OSF.IO/4FVDQ</ext-link></comment></nlm-citation></ref><ref id="ref16"><label>16</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murad</surname><given-names>MH</given-names> </name><name name-style="western"><surname>Wang</surname><given-names>Z</given-names> </name><name name-style="western"><surname>Chu</surname><given-names>H</given-names> </name><etal/></person-group><article-title>Proposed triggers for retiring a living systematic review</article-title><source>BMJ Evid Based Med</source><year>2023</year><month>10</month><volume>28</volume><issue>5</issue><fpage>348</fpage><lpage>352</lpage><pub-id pub-id-type="doi">10.1136/bmjebm-2022-112100</pub-id><pub-id pub-id-type="medline">36889900</pub-id></nlm-citation></ref><ref id="ref17"><label>17</label><nlm-citation citation-type="report"><person-group person-group-type="author"><collab>Cochrane Living Systematic Reviews Network</collab></person-group><article-title>Guidance for the production and publication of Cochrane living systematic reviews: Cochrane Reviews in living mode</article-title><year>2019</year><access-date>2026-01-13</access-date><publisher-name>Cochrane</publisher-name><comment><ext-link ext-link-type="uri" xlink:href="https://community.cochrane.org/sites/default/files/uploads/inline-files/Transform/201912_LSR_Revised_Guidance.pdf">https://community.cochrane.org/sites/default/files/uploads/inline-files/Transform/201912_LSR_Revised_Guidance.pdf</ext-link></comment></nlm-citation></ref><ref id="ref18"><label>18</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kozhakhmetova</surname><given-names>A</given-names> </name><name name-style="western"><surname>Mamyrbayev</surname><given-names>A</given-names> </name><name name-style="western"><surname>Zhidebekkyzy</surname><given-names>A</given-names> </name><name name-style="western"><surname>Bilan</surname><given-names>S</given-names> </name></person-group><article-title>Assessing the impact of artificial intelligence on project efficiency enhancement</article-title><source>Knowl Perform Manag</source><year>2024</year><volume>8</volume><issue>2</issue><fpage>109</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.21511/kpm.08(2).2024.09</pub-id></nlm-citation></ref><ref id="ref19"><label>19</label><nlm-citation citation-type="thesis"><person-group person-group-type="author"><name name-style="western"><surname>R&#x00F8;hl</surname><given-names>UBU</given-names> </name></person-group><article-title>Automated, administrative decision-making and good administration: friends, foes or complete strangers [Dissertation]</article-title><year>2022</year><access-date>2026-01-19</access-date><publisher-name>Aalborg Universitetsforlag</publisher-name><comment><ext-link ext-link-type="uri" xlink:href="https://vbn.aau.dk/ws/files/549540893/PHD_UBUR.pdf">https://vbn.aau.dk/ws/files/549540893/PHD_UBUR.pdf</ext-link></comment></nlm-citation></ref><ref id="ref20"><label>20</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khalil</surname><given-names>H</given-names> </name><name name-style="western"><surname>Ameen</surname><given-names>D</given-names> </name><name name-style="western"><surname>Zarnegar</surname><given-names>A</given-names> </name></person-group><article-title>Tools to support the automation of systematic reviews: a scoping review</article-title><source>J Clin Epidemiol</source><year>2022</year><month>04</month><volume>144</volume><fpage>22</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1016/j.jclinepi.2021.12.005</pub-id><pub-id pub-id-type="medline">34896236</pub-id></nlm-citation></ref><ref id="ref21"><label>21</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rashid</surname><given-names>M</given-names> </name><name name-style="western"><surname>Yi</surname><given-names>CS</given-names> </name><name name-style="western"><surname>Lawin</surname><given-names>S</given-names> </name><etal/></person-group><article-title>MT14 role of generative artificial intelligence in assisting systematic review process in health research: a systematic review</article-title><source>Value Health</source><year>2025</year><month>07</month><volume>28</volume><issue>6</issue><fpage>S268</fpage><pub-id pub-id-type="doi">10.1016/j.jval.2025.04.1124</pub-id><pub-id pub-id-type="medline">40848037</pub-id></nlm-citation></ref><ref id="ref22"><label>22</label><nlm-citation citation-type="web"><article-title>Validity assessment tools for evidence synthesis: your one-stop-shop</article-title><source>Latitudes Network</source><access-date>2026-01-13</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.latitudes-network.org">https://www.latitudes-network.org</ext-link></comment></nlm-citation></ref><ref id="ref23"><label>23</label><nlm-citation citation-type="web"><source>Equator Network - Enhancing the QUAlity and Transparency Of health Research</source><access-date>2025-08-06</access-date><comment><ext-link ext-link-type="uri" xlink:href="http://equator-network.org">http://equator-network.org</ext-link></comment></nlm-citation></ref><ref id="ref24"><label>24</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Whiting</surname><given-names>PF</given-names> </name><name name-style="western"><surname>Rutjes</surname><given-names>AWS</given-names> </name><name name-style="western"><surname>Westwood</surname><given-names>ME</given-names> </name><etal/></person-group><article-title>QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies</article-title><source>Ann Intern Med</source><year>2011</year><month>10</month><day>18</day><volume>155</volume><issue>8</issue><fpage>529</fpage><lpage>536</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-155-8-201110180-00009</pub-id><pub-id pub-id-type="medline">22007046</pub-id></nlm-citation></ref><ref id="ref25"><label>25</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santini</surname><given-names>A</given-names> </name><name name-style="western"><surname>Man</surname><given-names>A</given-names> </name><name name-style="western"><surname>Void&#x0103;zan</surname><given-names>S</given-names> </name></person-group><article-title>Accuracy of diagnostic tests</article-title><source>J Crit Care Med (Targu Mures)</source><year>2021</year><month>07</month><volume>7</volume><issue>3</issue><fpage>241</fpage><lpage>248</lpage><pub-id pub-id-type="doi">10.2478/jccm-2021-0022</pub-id><pub-id pub-id-type="medline">34722928</pub-id></nlm-citation></ref><ref id="ref26"><label>26</label><nlm-citation citation-type="book"><person-group person-group-type="author"><name name-style="western"><surname>McArthur</surname><given-names>A</given-names> </name><name name-style="western"><surname>Klugarova</surname><given-names>J</given-names> </name><name name-style="western"><surname>Yan</surname><given-names>H</given-names> </name><name name-style="western"><surname>Florescu</surname><given-names>S</given-names> </name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Aromataris</surname><given-names>E</given-names> </name><name name-style="western"><surname>Munn</surname><given-names>Z</given-names> </name></person-group><article-title>Chapter 4: systematic reviews of text and opinion</article-title><source>JBI Manual for Evidence Synthesis JBI</source><year>2020</year><publisher-name>JBI</publisher-name><pub-id pub-id-type="doi">10.46658/JBIRM-17-04</pub-id></nlm-citation></ref><ref id="ref27"><label>27</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shea</surname><given-names>BJ</given-names> </name><name name-style="western"><surname>Reeves</surname><given-names>BC</given-names> </name><name name-style="western"><surname>Wells</surname><given-names>G</given-names> </name><etal/></person-group><article-title>AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both</article-title><source>BMJ</source><year>2017</year><month>09</month><day>21</day><volume>358</volume><fpage>j4008</fpage><pub-id pub-id-type="doi">10.1136/bmj.j4008</pub-id><pub-id pub-id-type="medline">28935701</pub-id></nlm-citation></ref><ref id="ref28"><label>28</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Welsh</surname><given-names>EJ</given-names> </name><name name-style="western"><surname>Normansell</surname><given-names>RA</given-names> </name><name name-style="western"><surname>Cates</surname><given-names>CJ</given-names> </name></person-group><article-title>Assessing the methodological quality of systematic reviews</article-title><source>NPJ Prim Care Respir Med</source><year>2015</year><month>03</month><day>19</day><volume>25</volume><fpage>15019</fpage><pub-id pub-id-type="doi">10.1038/npjpcrm.2015.19</pub-id><pub-id pub-id-type="medline">25789911</pub-id></nlm-citation></ref><ref id="ref29"><label>29</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perlman-Arrow</surname><given-names>S</given-names> </name><name name-style="western"><surname>Loo</surname><given-names>N</given-names> </name><name name-style="western"><surname>Bobrovitz</surname><given-names>N</given-names> </name><name name-style="western"><surname>Yan</surname><given-names>T</given-names> </name><name name-style="western"><surname>Arora</surname><given-names>RK</given-names> </name></person-group><article-title>A real-world evaluation of the implementation of NLP technology in abstract screening of a systematic review</article-title><source>Res Synth Methods</source><year>2023</year><month>07</month><volume>14</volume><issue>4</issue><fpage>608</fpage><lpage>621</lpage><pub-id pub-id-type="doi">10.1002/jrsm.1636</pub-id><pub-id pub-id-type="medline">37230483</pub-id></nlm-citation></ref><ref id="ref30"><label>30</label><nlm-citation citation-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Higgins</surname><given-names>JPT</given-names> </name><name name-style="western"><surname>Thomas</surname><given-names>J</given-names> </name><name name-style="western"><surname>Chandler</surname><given-names>J</given-names> </name><etal/></person-group><source>Cochrane Handbook for Systematic Reviews of Interventions Version 6.5</source><year>2024</year><access-date>2026-01-13</access-date><publisher-name>Cochrane</publisher-name><comment><ext-link ext-link-type="uri" xlink:href="https://www.cochrane.org/authors/handbooks-and-manuals/handbook/current">https://www.cochrane.org/authors/handbooks-and-manuals/handbook/current</ext-link></comment></nlm-citation></ref><ref id="ref31"><label>31</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Campbell</surname><given-names>M</given-names> </name><name name-style="western"><surname>McKenzie</surname><given-names>JE</given-names> </name><name name-style="western"><surname>Sowden</surname><given-names>A</given-names> </name><etal/></person-group><article-title>Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline</article-title><source>BMJ</source><year>2020</year><month>01</month><day>16</day><volume>368</volume><fpage>l6890</fpage><pub-id pub-id-type="doi">10.1136/bmj.l6890</pub-id><pub-id pub-id-type="medline">31948937</pub-id></nlm-citation></ref><ref id="ref32"><label>32</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knafou</surname><given-names>J</given-names> </name><name name-style="western"><surname>Haas</surname><given-names>Q</given-names> </name><name name-style="western"><surname>Borissov</surname><given-names>N</given-names> </name><etal/></person-group><article-title>Ensemble of deep learning language models to support the creation of living systematic reviews for the COVID-19 literature</article-title><source>Syst Rev</source><year>2023</year><month>06</month><day>5</day><volume>12</volume><issue>1</issue><fpage>94</fpage><pub-id pub-id-type="doi">10.1186/s13643-023-02247-9</pub-id><pub-id pub-id-type="medline">37277872</pub-id></nlm-citation></ref><ref id="ref33"><label>33</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matl</surname><given-names>S</given-names> </name><name name-style="western"><surname>Brosig</surname><given-names>R</given-names> </name><name name-style="western"><surname>Baust</surname><given-names>M</given-names> </name><name name-style="western"><surname>Navab</surname><given-names>N</given-names> </name><name name-style="western"><surname>Demirci</surname><given-names>S</given-names> </name></person-group><article-title>Vascular image registration techniques: a living review</article-title><source>Med Image Anal</source><year>2017</year><month>01</month><volume>35</volume><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1016/j.media.2016.05.005</pub-id><pub-id pub-id-type="medline">27294558</pub-id></nlm-citation></ref><ref id="ref34"><label>34</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schmidt</surname><given-names>L</given-names> </name><name name-style="western"><surname>Finnerty Mutlu</surname><given-names>AN</given-names> </name><name name-style="western"><surname>Elmore</surname><given-names>R</given-names> </name><name name-style="western"><surname>Olorisade</surname><given-names>BK</given-names> </name><name name-style="western"><surname>Thomas</surname><given-names>J</given-names> </name><name name-style="western"><surname>Higgins</surname><given-names>JPT</given-names> </name></person-group><article-title>Data extraction methods for systematic review (semi)automation: update of a living systematic review</article-title><source>F1000Res</source><year>2021</year><volume>10</volume><fpage>401</fpage><pub-id pub-id-type="doi">10.12688/f1000research.51117.3</pub-id><pub-id pub-id-type="medline">34408850</pub-id></nlm-citation></ref><ref id="ref35"><label>35</label><nlm-citation citation-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Chou</surname><given-names>R</given-names> </name><name name-style="western"><surname>Dana</surname><given-names>T</given-names> </name><name name-style="western"><surname>Shetty</surname><given-names>KD</given-names> </name></person-group><source>Testing a Machine Learning Tool for Facilitating Living Systematic Reviews of Chronic Pain Treatments</source><year>2020</year><publisher-name>Agency for Healthcare Research and Quality</publisher-name><pub-id pub-id-type="medline">33175480</pub-id></nlm-citation></ref><ref id="ref36"><label>36</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kamso</surname><given-names>MM</given-names> </name><name name-style="western"><surname>Pardo</surname><given-names>JP</given-names> </name><name name-style="western"><surname>Whittle</surname><given-names>SL</given-names> </name><etal/></person-group><article-title>Crowd-sourcing and automation facilitated the identification and classification of randomized controlled trials in a living review</article-title><source>J Clin Epidemiol</source><year>2023</year><month>12</month><volume>164</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.jclinepi.2023.10.007</pub-id><pub-id pub-id-type="medline">37865299</pub-id></nlm-citation></ref><ref id="ref37"><label>37</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Riaz</surname><given-names>IB</given-names> </name><name name-style="western"><surname>Sipra</surname><given-names>Q</given-names> </name><name name-style="western"><surname>Naqvi</surname><given-names>SAA</given-names> </name><etal/></person-group><article-title>Quantifying absolute benefit for adjuvant treatment options in renal cell carcinoma: a living interactive systematic review and network meta-analysis</article-title><source>Crit Rev Oncol Hematol</source><year>2022</year><month>07</month><volume>175</volume><fpage>103706</fpage><pub-id pub-id-type="doi">10.1016/j.critrevonc.2022.103706</pub-id><pub-id pub-id-type="medline">35537621</pub-id></nlm-citation></ref><ref id="ref38"><label>38</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Butler</surname><given-names>AR</given-names> </name><name name-style="western"><surname>Hartmann-Boyce</surname><given-names>J</given-names> </name><name name-style="western"><surname>Livingstone-Banks</surname><given-names>J</given-names> </name><name name-style="western"><surname>Turner</surname><given-names>T</given-names> </name><name name-style="western"><surname>Lindson</surname><given-names>N</given-names> </name></person-group><article-title>Optimizing process and methods for a living systematic review: 30 search updates and three review updates later</article-title><source>J Clin Epidemiol</source><year>2024</year><month>02</month><volume>166</volume><fpage>111231</fpage><pub-id pub-id-type="doi">10.1016/j.jclinepi.2023.111231</pub-id><pub-id pub-id-type="medline">38043829</pub-id></nlm-citation></ref><ref id="ref39"><label>39</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Riaz</surname><given-names>IB</given-names> </name><name name-style="western"><surname>He</surname><given-names>H</given-names> </name><name name-style="western"><surname>Ryu</surname><given-names>AJ</given-names> </name><etal/></person-group><article-title>A living, interactive systematic review and network meta-analysis of first-line treatment of metastatic renal cell carcinoma</article-title><source>Eur Urol</source><year>2021</year><month>12</month><volume>80</volume><issue>6</issue><fpage>712</fpage><lpage>723</lpage><pub-id pub-id-type="doi">10.1016/j.eururo.2021.03.016</pub-id><pub-id pub-id-type="medline">33824031</pub-id></nlm-citation></ref><ref id="ref40"><label>40</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Riaz</surname><given-names>IB</given-names> </name><name name-style="western"><surname>Siddiqi</surname><given-names>R</given-names> </name><name name-style="western"><surname>Islam</surname><given-names>M</given-names> </name><etal/></person-group><article-title>Adjuvant tyrosine kinase inhibitors in renal cell carcinoma: a concluded living systematic review and meta-analysis</article-title><source>JCO Clin Cancer Inform</source><year>2021</year><month>05</month><volume>5</volume><fpage>588</fpage><lpage>599</lpage><pub-id pub-id-type="doi">10.1200/CCI.21.00035</pub-id><pub-id pub-id-type="medline">34043431</pub-id></nlm-citation></ref><ref id="ref41"><label>41</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hair</surname><given-names>K</given-names> </name><name name-style="western"><surname>Wilson</surname><given-names>E</given-names> </name><name name-style="western"><surname>Wong</surname><given-names>C</given-names> </name><name name-style="western"><surname>Tsang</surname><given-names>A</given-names> </name><name name-style="western"><surname>Macleod</surname><given-names>M</given-names> </name><name name-style="western"><surname>Bannach-Brown</surname><given-names>A</given-names> </name></person-group><article-title>Systematic online living evidence summaries: emerging tools to accelerate evidence synthesis</article-title><source>Clin Sci (Lond)</source><year>2023</year><month>05</month><day>31</day><volume>137</volume><issue>10</issue><fpage>773</fpage><lpage>784</lpage><pub-id pub-id-type="doi">10.1042/CS20220494</pub-id><pub-id pub-id-type="medline">37219941</pub-id></nlm-citation></ref><ref id="ref42"><label>42</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marshall</surname><given-names>IJ</given-names> </name><name name-style="western"><surname>Trikalinos</surname><given-names>TA</given-names> </name><name name-style="western"><surname>Soboczenski</surname><given-names>F</given-names> </name><etal/></person-group><article-title>In a pilot study, automated real-time systematic review updates were feasible, accurate, and work-saving</article-title><source>J Clin Epidemiol</source><year>2023</year><month>01</month><volume>153</volume><fpage>26</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1016/j.jclinepi.2022.08.013</pub-id><pub-id pub-id-type="medline">36150548</pub-id></nlm-citation></ref><ref id="ref43"><label>43</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haas</surname><given-names>Q</given-names> </name><name name-style="western"><surname>Alvarez</surname><given-names>DV</given-names> </name><name name-style="western"><surname>Borissov</surname><given-names>N</given-names> </name><etal/></person-group><article-title>Utilizing artificial intelligence to manage COVID-19 scientific evidence torrent with Risklick AI: a critical tool for pharmacology and therapy development</article-title><source>Pharmacology</source><year>2021</year><volume>106</volume><issue>5-6</issue><fpage>244</fpage><lpage>253</lpage><pub-id pub-id-type="doi">10.1159/000515908</pub-id><pub-id pub-id-type="medline">33910199</pub-id></nlm-citation></ref><ref id="ref44"><label>44</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vaghela</surname><given-names>U</given-names> </name><name name-style="western"><surname>Rabinowicz</surname><given-names>S</given-names> </name><name name-style="western"><surname>Bratsos</surname><given-names>P</given-names> </name><etal/></person-group><article-title>Using a secure, continually updating, web source processing pipeline to support the real-time data synthesis and analysis of scientific literature: development and validation study</article-title><source>J Med Internet Res</source><year>2021</year><month>05</month><day>6</day><volume>23</volume><issue>5</issue><fpage>e25714</fpage><pub-id pub-id-type="doi">10.2196/25714</pub-id><pub-id pub-id-type="medline">33835932</pub-id></nlm-citation></ref><ref id="ref45"><label>45</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karak&#x00FC;lah</surname><given-names>G</given-names> </name><name name-style="western"><surname>Suner</surname><given-names>A</given-names> </name><name name-style="western"><surname>Adlassnig</surname><given-names>KP</given-names> </name><name name-style="western"><surname>Samwald</surname><given-names>M</given-names> </name></person-group><article-title>A data-driven living review for pharmacogenomic decision support in cancer treatment</article-title><source>Stud Health Technol Inform</source><year>2012</year><volume>180</volume><fpage>688</fpage><lpage>692</lpage><pub-id pub-id-type="doi">10.3233/978-1-61499-101-4-688</pub-id><pub-id pub-id-type="medline">22874279</pub-id></nlm-citation></ref><ref id="ref46"><label>46</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xin</surname><given-names>Y</given-names> </name><name name-style="western"><surname>Nevill</surname><given-names>CR</given-names> </name><name name-style="western"><surname>Nevill</surname><given-names>J</given-names> </name><etal/></person-group><article-title>Feasibility study for interactive reporting of network meta-analysis: experiences from the development of the Metainsight COVID-19 app for stakeholder exploration, re-analysis and sensitivity analysis from living systematic reviews</article-title><source>BMC Med Res Methodol</source><year>2022</year><month>01</month><day>22</day><volume>22</volume><issue>1</issue><fpage>26</fpage><pub-id pub-id-type="doi">10.1186/s12874-022-01507-x</pub-id><pub-id pub-id-type="medline">35065603</pub-id></nlm-citation></ref><ref id="ref47"><label>47</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Evrenoglou</surname><given-names>T</given-names> </name><name name-style="western"><surname>Boutron</surname><given-names>I</given-names> </name><name name-style="western"><surname>Seitidis</surname><given-names>G</given-names> </name><name name-style="western"><surname>Ghosn</surname><given-names>L</given-names> </name><name name-style="western"><surname>Chaimani</surname><given-names>A</given-names> </name></person-group><article-title>metaCOVID: a web-application for living meta-analyses of COVID-19 trials</article-title><source>Res Synth Methods</source><year>2023</year><month>05</month><volume>14</volume><issue>3</issue><fpage>479</fpage><lpage>488</lpage><pub-id pub-id-type="doi">10.1002/jrsm.1627</pub-id><pub-id pub-id-type="medline">36772980</pub-id></nlm-citation></ref><ref id="ref48"><label>48</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaiser</surname><given-names>K</given-names> </name><name name-style="western"><surname>Miksch</surname><given-names>S</given-names> </name></person-group><article-title>Versioning computer-interpretable guidelines: semi-automatic modeling of &#x201C;living guidelines&#x201D; using an information extraction method</article-title><source>Artif Intell Med</source><year>2009</year><month>05</month><volume>46</volume><issue>1</issue><fpage>55</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1016/j.artmed.2008.08.009</pub-id><pub-id pub-id-type="medline">18950994</pub-id></nlm-citation></ref><ref id="ref49"><label>49</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Skinner</surname><given-names>G</given-names> </name><name name-style="western"><surname>Cooke</surname><given-names>R</given-names> </name><name name-style="western"><surname>Keum</surname><given-names>J</given-names> </name><etal/></person-group><article-title>Dynameta: a dynamic platform for ecological meta-analyses in R Shiny</article-title><source>SoftwareX</source><year>2023</year><month>07</month><volume>23</volume><fpage>101439</fpage><pub-id pub-id-type="doi">10.1016/j.softx.2023.101439</pub-id></nlm-citation></ref><ref id="ref50"><label>50</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McDonald</surname><given-names>S</given-names> </name><name name-style="western"><surname>Hill</surname><given-names>K</given-names> </name><name name-style="western"><surname>Li</surname><given-names>HZ</given-names> </name><name name-style="western"><surname>Turner</surname><given-names>T</given-names> </name></person-group><article-title>Evidence surveillance for a living clinical guideline: case study of the Australian stroke guidelines</article-title><source>Health Info Libr J</source><year>2023</year><month>11</month><day>9</day><pub-id pub-id-type="doi">10.1111/hir.12515</pub-id><pub-id pub-id-type="medline">37942888</pub-id></nlm-citation></ref><ref id="ref51"><label>51</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shemilt</surname><given-names>I</given-names> </name><name name-style="western"><surname>Arno</surname><given-names>A</given-names> </name><name name-style="western"><surname>Thomas</surname><given-names>J</given-names> </name><etal/></person-group><article-title>Cost-effectiveness of Microsoft Academic Graph with machine learning for automated study identification in a living map of coronavirus disease 2019 (COVID-19) research</article-title><source>Wellcome Open Res</source><year>2024</year><volume>6</volume><fpage>210</fpage><pub-id pub-id-type="doi">10.12688/wellcomeopenres.17141.2</pub-id><pub-id pub-id-type="medline">38686019</pub-id></nlm-citation></ref><ref id="ref52"><label>52</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Le-Khac</surname><given-names>UN</given-names> </name><name name-style="western"><surname>Bolton</surname><given-names>M</given-names> </name><name name-style="western"><surname>Boxall</surname><given-names>NJ</given-names> </name><name name-style="western"><surname>Wallace</surname><given-names>SMN</given-names> </name><name name-style="western"><surname>George</surname><given-names>Y</given-names> </name></person-group><article-title>Living review framework for better policy design and management of hazardous waste in Australia</article-title><source>Sci Total Environ</source><year>2024</year><month>05</month><day>10</day><volume>924</volume><fpage>171556</fpage><pub-id pub-id-type="doi">10.1016/j.scitotenv.2024.171556</pub-id><pub-id pub-id-type="medline">38458450</pub-id></nlm-citation></ref><ref id="ref53"><label>53</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khan</surname><given-names>MA</given-names> </name><name name-style="western"><surname>Ayub</surname><given-names>U</given-names> </name><name name-style="western"><surname>Naqvi</surname><given-names>SAA</given-names> </name><etal/></person-group><article-title>Collaborative large language models for automated data extraction in living systematic reviews</article-title><source>J Am Med Inform Assoc</source><year>2025</year><month>04</month><day>1</day><volume>32</volume><issue>4</issue><fpage>638</fpage><lpage>647</lpage><pub-id pub-id-type="doi">10.1093/jamia/ocae325</pub-id><pub-id pub-id-type="medline">39836495</pub-id></nlm-citation></ref><ref id="ref54"><label>54</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hair</surname><given-names>K</given-names> </name><name name-style="western"><surname>Wilson</surname><given-names>E</given-names> </name><name name-style="western"><surname>Maksym</surname><given-names>O</given-names> </name><name name-style="western"><surname>Macleod</surname><given-names>MR</given-names> </name><name name-style="western"><surname>Sena</surname><given-names>ES</given-names> </name></person-group><article-title>A systematic online living evidence summary of experimental Alzheimer&#x2019;s disease research</article-title><source>J Neurosci Methods</source><year>2024</year><month>09</month><volume>409</volume><fpage>110209</fpage><pub-id pub-id-type="doi">10.1016/j.jneumeth.2024.110209</pub-id><pub-id pub-id-type="medline">38964475</pub-id></nlm-citation></ref><ref id="ref55"><label>55</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grbin</surname><given-names>L</given-names> </name><name name-style="western"><surname>Nichols</surname><given-names>P</given-names> </name><name name-style="western"><surname>Russell</surname><given-names>F</given-names> </name><name name-style="western"><surname>Fuller-Tyszkiewicz</surname><given-names>M</given-names> </name><name name-style="western"><surname>Olsson</surname><given-names>CA</given-names> </name></person-group><article-title>The development of a living knowledge system and implications for future systematic searching</article-title><source>J Aust Libr Inf Assoc</source><year>2022</year><month>07</month><day>3</day><volume>71</volume><issue>3</issue><fpage>275</fpage><lpage>292</lpage><pub-id pub-id-type="doi">10.1080/24750158.2022.2087954</pub-id></nlm-citation></ref><ref id="ref56"><label>56</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hearnden</surname><given-names>J</given-names> </name><name name-style="western"><surname>Dudoit</surname><given-names>K</given-names> </name><name name-style="western"><surname>Kim</surname><given-names>E</given-names> </name><name name-style="western"><surname>Tremblay</surname><given-names>G</given-names> </name><name name-style="western"><surname>Forsythe</surname><given-names>A</given-names> </name></person-group><article-title>PMU118 use of computer-assisted methods to realize the concept of a living systematic review via an online platform</article-title><source>Value Health</source><year>2019</year><month>11</month><volume>22</volume><fpage>S729</fpage><pub-id pub-id-type="doi">10.1016/j.jval.2019.09.1736</pub-id></nlm-citation></ref><ref id="ref57"><label>57</label><nlm-citation citation-type="other"><person-group person-group-type="author"><name name-style="western"><surname>Evrenoglou</surname><given-names>T</given-names> </name><name name-style="western"><surname>Boutron</surname><given-names>I</given-names> </name><name name-style="western"><surname>Chaimani</surname><given-names>A</given-names> </name></person-group><article-title>metaCOVID: an R-Shiny application for living meta-analyses of COVID-19 trials</article-title><source>medRxiv</source><comment>Preprint posted online on  Sep 10, 2021</comment><pub-id pub-id-type="doi">10.1101/2021.09.07.21263207</pub-id></nlm-citation></ref><ref id="ref58"><label>58</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stoll</surname><given-names>A</given-names> </name><name name-style="western"><surname>Wilms</surname><given-names>L</given-names> </name><name name-style="western"><surname>Ziegele</surname><given-names>M</given-names> </name></person-group><article-title>Developing an incivility dictionary for German online discussions&#x2014;a semi-automated approach combining human and artificial knowledge</article-title><source>Commun Methods Meas</source><year>2023</year><month>04</month><day>3</day><volume>17</volume><issue>2</issue><fpage>131</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1080/19312458.2023.2166028</pub-id></nlm-citation></ref><ref id="ref59"><label>59</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meza</surname><given-names>N</given-names> </name><name name-style="western"><surname>P&#x00E9;rez-Bracchiglione</surname><given-names>J</given-names> </name><name name-style="western"><surname>P&#x00E9;rez</surname><given-names>I</given-names> </name><etal/></person-group><article-title>Angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers for COVID-19: a living systematic review of randomized clinical trials</article-title><source>Medwave</source><year>2021</year><month>03</month><day>3</day><volume>21</volume><issue>2</issue><fpage>e8105</fpage><pub-id pub-id-type="doi">10.5867/medwave.2021.02.8105</pub-id><pub-id pub-id-type="medline">33830976</pub-id></nlm-citation></ref><ref id="ref60"><label>60</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Verdejo</surname><given-names>C</given-names> </name><name name-style="western"><surname>Vergara-Merino</surname><given-names>L</given-names> </name><name name-style="western"><surname>Meza</surname><given-names>N</given-names> </name><etal/></person-group><article-title>Macrolides for the treatment of COVID-19: a living, systematic review</article-title><source>Medwave</source><year>2020</year><month>12</month><day>14</day><volume>20</volume><issue>11</issue><fpage>e8074</fpage><pub-id pub-id-type="doi">10.5867/medwave.2020.11.8073</pub-id><pub-id pub-id-type="medline">33361755</pub-id></nlm-citation></ref><ref id="ref61"><label>61</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baladia</surname><given-names>E</given-names> </name><name name-style="western"><surname>Pizarro</surname><given-names>AB</given-names> </name><name name-style="western"><surname>Ortiz-Mu&#x00F1;oz</surname><given-names>L</given-names> </name><name name-style="western"><surname>Rada</surname><given-names>G</given-names> </name></person-group><article-title>Vitamin C for COVID-19: a living systematic review</article-title><source>Medwave</source><year>2020</year><month>07</month><day>28</day><volume>20</volume><issue>6</issue><fpage>e7978</fpage><pub-id pub-id-type="doi">10.5867/medwave.2020.06.7978</pub-id><pub-id pub-id-type="medline">32759894</pub-id></nlm-citation></ref><ref id="ref62"><label>62</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rada</surname><given-names>G</given-names> </name><name name-style="western"><surname>Corbal&#x00E1;n</surname><given-names>J</given-names> </name><name name-style="western"><surname>Rojas</surname><given-names>P</given-names> </name><collab>COVID-19 L&#x00B7;OVE Working Group</collab></person-group><article-title>Cell-based therapies for COVID-19: a living, systematic review</article-title><source>Medwave</source><year>2020</year><month>12</month><day>17</day><volume>20</volume><issue>11</issue><fpage>e8079</fpage><pub-id pub-id-type="doi">10.5867/medwave.2020.11.8078</pub-id><pub-id pub-id-type="medline">33382060</pub-id></nlm-citation></ref><ref id="ref63"><label>63</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gates</surname><given-names>M</given-names> </name><name name-style="western"><surname>Elliott</surname><given-names>SA</given-names> </name><name name-style="western"><surname>Gates</surname><given-names>A</given-names> </name><etal/></person-group><article-title>LOCATE: a prospective evaluation of the value of leveraging ongoing citation acquisition techniques for living evidence syntheses</article-title><source>Syst Rev</source><year>2021</year><month>04</month><day>19</day><volume>10</volume><issue>1</issue><fpage>116</fpage><pub-id pub-id-type="doi">10.1186/s13643-021-01665-x</pub-id><pub-id pub-id-type="medline">33875014</pub-id></nlm-citation></ref><ref id="ref64"><label>64</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Piechotta</surname><given-names>V</given-names> </name><name name-style="western"><surname>Iannizzi</surname><given-names>C</given-names> </name><name name-style="western"><surname>Chai</surname><given-names>KL</given-names> </name><etal/></person-group><article-title>Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review</article-title><source>Cochrane Database Syst Rev</source><year>2021</year><month>05</month><day>20</day><volume>5</volume><issue>5</issue><fpage>CD013600</fpage><pub-id pub-id-type="doi">10.1002/14651858.CD013600.pub4</pub-id><pub-id pub-id-type="medline">34013969</pub-id></nlm-citation></ref><ref id="ref65"><label>65</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Verdugo-Paiva</surname><given-names>F</given-names> </name><name name-style="western"><surname>Acu&#x00F1;a</surname><given-names>MP</given-names> </name><name name-style="western"><surname>Sol&#x00E1;</surname><given-names>I</given-names> </name><name name-style="western"><surname>Rada</surname><given-names>G</given-names> </name><collab>COVID-19 L&#x00B7;OVE Working Group</collab></person-group><article-title>Remdesivir for the treatment of COVID-19: a living systematic review</article-title><source>Medwave</source><year>2020</year><month>12</month><day>9</day><volume>20</volume><issue>11</issue><fpage>e8080</fpage><pub-id pub-id-type="doi">10.5867/medwave.2020.11.8080</pub-id><pub-id pub-id-type="medline">33361753</pub-id></nlm-citation></ref><ref id="ref66"><label>66</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shackelford</surname><given-names>GE</given-names> </name><name name-style="western"><surname>Martin</surname><given-names>PA</given-names> </name><name name-style="western"><surname>Hood</surname><given-names>ASC</given-names> </name><name name-style="western"><surname>Christie</surname><given-names>AP</given-names> </name><name name-style="western"><surname>Kulinskaya</surname><given-names>E</given-names> </name><name name-style="western"><surname>Sutherland</surname><given-names>WJ</given-names> </name></person-group><article-title>Dynamic meta-analysis: a method of using global evidence for local decision making</article-title><source>BMC Biol</source><year>2021</year><month>02</month><day>17</day><volume>19</volume><issue>1</issue><fpage>33</fpage><pub-id pub-id-type="doi">10.1186/s12915-021-00974-w</pub-id><pub-id pub-id-type="medline">33596922</pub-id></nlm-citation></ref><ref id="ref67"><label>67</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Verdugo-Paiva</surname><given-names>F</given-names> </name><name name-style="western"><surname>Izcovich</surname><given-names>A</given-names> </name><name name-style="western"><surname>Ragusa</surname><given-names>M</given-names> </name><name name-style="western"><surname>Rada</surname><given-names>G</given-names> </name></person-group><article-title>Lopinavir-ritonavir for COVID-19: a living systematic review</article-title><source>Medwave</source><year>2020</year><month>07</month><day>15</day><volume>20</volume><issue>6</issue><fpage>e7967</fpage><pub-id pub-id-type="doi">10.5867/medwave.2020.06.7966</pub-id><pub-id pub-id-type="medline">32678815</pub-id></nlm-citation></ref><ref id="ref68"><label>68</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Iannizzi</surname><given-names>C</given-names> </name><name name-style="western"><surname>Chai</surname><given-names>KL</given-names> </name><name name-style="western"><surname>Piechotta</surname><given-names>V</given-names> </name><etal/></person-group><article-title>Convalescent plasma for people with COVID-19: a living systematic review</article-title><source>Cochrane Database Syst Rev</source><year>2023</year><month>02</month><day>1</day><volume>2</volume><issue>2</issue><fpage>CD013600</fpage><pub-id pub-id-type="doi">10.1002/14651858.CD013600.pub5</pub-id><pub-id pub-id-type="medline">36734509</pub-id></nlm-citation></ref><ref id="ref69"><label>69</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sommer</surname><given-names>I</given-names> </name><name name-style="western"><surname>Ledinger</surname><given-names>D</given-names> </name><name name-style="western"><surname>Thaler</surname><given-names>K</given-names> </name><etal/></person-group><article-title>Outpatient treatment of confirmed COVID-19: a living, rapid evidence review for the American College of Physicians (Version 2)</article-title><source>Ann Intern Med</source><year>2023</year><month>10</month><volume>176</volume><issue>10</issue><fpage>1377</fpage><lpage>1385</lpage><pub-id pub-id-type="doi">10.7326/M23-1626</pub-id><pub-id pub-id-type="medline">37722115</pub-id></nlm-citation></ref><ref id="ref70"><label>70</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Verdugo-Paiva</surname><given-names>F</given-names> </name><name name-style="western"><surname>Vergara</surname><given-names>C</given-names> </name><name name-style="western"><surname>&#x00C1;vila</surname><given-names>C</given-names> </name><etal/></person-group><article-title>COVID-19 living overview of evidence repository is highly comprehensive and can be used as a single source for COVID-19 studies</article-title><source>J Clin Epidemiol</source><year>2022</year><month>09</month><volume>149</volume><fpage>195</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1016/j.jclinepi.2022.05.001</pub-id><pub-id pub-id-type="medline">35597369</pub-id></nlm-citation></ref><ref id="ref71"><label>71</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paul</surname><given-names>D</given-names> </name><name name-style="western"><surname>Chakdar</surname><given-names>D</given-names> </name><name name-style="western"><surname>Saha</surname><given-names>S</given-names> </name><name name-style="western"><surname>Mathew</surname><given-names>J</given-names> </name></person-group><article-title>Online research topic modeling and recommendation utilizing multiview autoencoder-based approach</article-title><source>IEEE Trans Comput Soc Syst</source><year>2024</year><volume>11</volume><issue>1</issue><fpage>1013</fpage><lpage>1022</lpage><pub-id pub-id-type="doi">10.1109/TCSS.2023.3253502</pub-id></nlm-citation></ref><ref id="ref72"><label>72</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vergara-Merino</surname><given-names>L</given-names> </name><name name-style="western"><surname>Verdejo</surname><given-names>C</given-names> </name><name name-style="western"><surname>Carrasco</surname><given-names>C</given-names> </name><name name-style="western"><surname>Vargas-Peirano</surname><given-names>M</given-names> </name></person-group><article-title>Living systematic review: new inputs and challenges</article-title><source>Medwave</source><year>2020</year><month>12</month><day>23</day><volume>20</volume><issue>11</issue><fpage>e8092</fpage><pub-id pub-id-type="doi">10.5867/medwave.2020.11.8092</pub-id><pub-id pub-id-type="medline">33382391</pub-id></nlm-citation></ref><ref id="ref73"><label>73</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elbers</surname><given-names>S</given-names> </name><name name-style="western"><surname>Wittink</surname><given-names>H</given-names> </name><name name-style="western"><surname>Kaiser</surname><given-names>U</given-names> </name><etal/></person-group><article-title>Living systematic reviews in rehabilitation science can improve evidence-based healthcare</article-title><source>Syst Rev</source><year>2021</year><month>12</month><day>7</day><volume>10</volume><issue>1</issue><fpage>309</fpage><pub-id pub-id-type="doi">10.1186/s13643-021-01857-5</pub-id><pub-id pub-id-type="medline">34876231</pub-id></nlm-citation></ref><ref id="ref74"><label>74</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elvidge</surname><given-names>J</given-names> </name><name name-style="western"><surname>Hopkin</surname><given-names>G</given-names> </name><name name-style="western"><surname>Narayanan</surname><given-names>N</given-names> </name><name name-style="western"><surname>Nicholls</surname><given-names>D</given-names> </name><name name-style="western"><surname>Dawoud</surname><given-names>D</given-names> </name></person-group><article-title>Diagnostics and treatments of COVID-19: two-year update to a living systematic review of economic evaluations</article-title><source>Front Pharmacol</source><year>2023</year><volume>14</volume><fpage>1291164</fpage><pub-id pub-id-type="doi">10.3389/fphar.2023.1291164</pub-id><pub-id pub-id-type="medline">38035028</pub-id></nlm-citation></ref><ref id="ref75"><label>75</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Winters</surname><given-names>M</given-names> </name><name name-style="western"><surname>Lyng</surname><given-names>KD</given-names> </name><name name-style="western"><surname>Holden</surname><given-names>S</given-names> </name><etal/></person-group><article-title>Infographic. Comparative effectiveness of treatments for patellofemoral pain: a living systematic review with network meta-analysis</article-title><source>Br J Sports Med</source><year>2021</year><month>11</month><volume>55</volume><issue>22</issue><fpage>1311</fpage><lpage>1312</lpage><pub-id pub-id-type="doi">10.1136/bjsports-2021-104360</pub-id><pub-id pub-id-type="medline">34244170</pub-id></nlm-citation></ref><ref id="ref76"><label>76</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Katanandov</surname><given-names>SL</given-names> </name><name name-style="western"><surname>Kovalev</surname><given-names>AA</given-names> </name></person-group><article-title>Technological development of modern states: artificial intelligence in public administration</article-title><source>State and Municipal Management Scholar Notes</source><year>2023</year><month>03</month><volume>1</volume><issue>1</issue><fpage>174</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.22394/2079-1690-2023-1-1-174-182</pub-id></nlm-citation></ref><ref id="ref77"><label>77</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Medaglia</surname><given-names>R</given-names> </name><name name-style="western"><surname>Gil-Garcia</surname><given-names>JR</given-names> </name><name name-style="western"><surname>Pardo</surname><given-names>TA</given-names> </name></person-group><article-title>Artificial intelligence in government: taking stock and moving forward</article-title><source>Soc Sci Comput Rev</source><year>2021</year><volume>41</volume><issue>1</issue><fpage>123</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1177/08944393211034087</pub-id></nlm-citation></ref><ref id="ref78"><label>78</label><nlm-citation citation-type="report"><person-group person-group-type="author"><name name-style="western"><surname>Thomas</surname><given-names>J</given-names> </name><name name-style="western"><surname>Flemyng</surname><given-names>E</given-names> </name><name name-style="western"><surname>Noel-Storr</surname><given-names>A</given-names> </name><etal/></person-group><article-title>Responsible AI in Evidence SynthEsis (RAISE): guidance and recommendations</article-title><year>2024</year><access-date>2026-01-13</access-date><publisher-name>Open Science Framework</publisher-name><comment><ext-link ext-link-type="uri" xlink:href="https://osf.io/fwaud/files/cn7x4">https://osf.io/fwaud/files/cn7x4</ext-link></comment></nlm-citation></ref><ref id="ref79"><label>79</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Filetti</surname><given-names>S</given-names> </name><name name-style="western"><surname>Fenza</surname><given-names>G</given-names> </name><name name-style="western"><surname>Gallo</surname><given-names>A</given-names> </name></person-group><article-title>Research design and writing of scholarly articles: new artificial intelligence tools available for researchers</article-title><source>Endocrine</source><year>2024</year><month>09</month><volume>85</volume><issue>3</issue><fpage>1104</fpage><lpage>1116</lpage><pub-id pub-id-type="doi">10.1007/s12020-024-03977-z</pub-id><pub-id pub-id-type="medline">39085566</pub-id></nlm-citation></ref><ref id="ref80"><label>80</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramnani</surname><given-names>S</given-names> </name></person-group><article-title>Exploring ethical considerations of artificial intelligence in educational settings: an examination of bias, privacy, and accountability</article-title><source>International Journal of Novel Research and Development</source><year>2024</year><volume>9</volume><issue>2</issue><fpage>b173</fpage><lpage>b191</lpage><pub-id pub-id-type="doi">10.1729/Journal.37869</pub-id></nlm-citation></ref><ref id="ref81"><label>81</label><nlm-citation citation-type="other"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Y</given-names> </name><name name-style="western"><surname>Shao</surname><given-names>S</given-names> </name><name name-style="western"><surname>He</surname><given-names>Y</given-names> </name><etal/></person-group><article-title>Rethinking data protection in the (generative) artificial intelligence era</article-title><source>arXiv</source><comment>Preprint posted online on  Jul 3, 2025</comment><pub-id pub-id-type="doi">10.48550/arXiv.2507.03034</pub-id></nlm-citation></ref><ref id="ref82"><label>82</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Umeh</surname><given-names>II</given-names> </name><name name-style="western"><surname>Umeh</surname><given-names>KC</given-names> </name></person-group><article-title>A comparative analysis of AI system development tools for improved outcomes</article-title><source>International Journal of Sustainability Management and Information Technologies</source><year>2025</year><volume>11</volume><fpage>1</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.11648/j.ijsmit.20251101.11</pub-id></nlm-citation></ref><ref id="ref83"><label>83</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ram&#x00ED;rez</surname><given-names>G</given-names> </name></person-group><article-title>Improving the health of populations&#x2014;evidence for policy and practice action</article-title><source>J Evid Based Med</source><year>2009</year><month>11</month><volume>2</volume><issue>4</issue><fpage>216</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.1111/j.1756-5391.2009.01044.x</pub-id><pub-id pub-id-type="medline">21349019</pub-id></nlm-citation></ref><ref id="ref84"><label>84</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Manson</surname><given-names>H</given-names> </name></person-group><article-title>Systematic reviews are not enough: policymakers need a greater variety of synthesized evidence</article-title><source>J Clin Epidemiol</source><year>2016</year><month>05</month><volume>73</volume><fpage>11</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/j.jclinepi.2015.08.032</pub-id><pub-id pub-id-type="medline">26912122</pub-id></nlm-citation></ref><ref id="ref85"><label>85</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Berger-Tal</surname><given-names>O</given-names> </name><name name-style="western"><surname>Wong</surname><given-names>BBM</given-names> </name><name name-style="western"><surname>Adams</surname><given-names>CA</given-names> </name><etal/></person-group><article-title>Leveraging AI to improve evidence synthesis in conservation</article-title><source>Trends Ecol Evol</source><year>2024</year><month>06</month><volume>39</volume><issue>6</issue><fpage>548</fpage><lpage>557</lpage><pub-id pub-id-type="doi">10.1016/j.tree.2024.04.007</pub-id><pub-id pub-id-type="medline">38796352</pub-id></nlm-citation></ref><ref id="ref86"><label>86</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jacob</surname><given-names>S</given-names> </name></person-group><article-title>Artificial intelligence and the future of evaluation: from augmented to automated evaluation</article-title><source>Digit Gov Res Pract</source><year>2025</year><month>03</month><day>31</day><volume>6</volume><issue>1</issue><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1145/3696009</pub-id></nlm-citation></ref><ref id="ref87"><label>87</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Head</surname><given-names>CB</given-names> </name><name name-style="western"><surname>Jasper</surname><given-names>P</given-names> </name><name name-style="western"><surname>McConnachie</surname><given-names>M</given-names> </name><name name-style="western"><surname>Raftree</surname><given-names>L</given-names> </name><name name-style="western"><surname>Higdon</surname><given-names>G</given-names> </name></person-group><article-title>Large language model applications for evaluation: opportunities and ethical implications</article-title><source>New Dir Eval</source><year>2023</year><month>06</month><volume>2023</volume><issue>178-179</issue><fpage>33</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1002/ev.20556</pub-id></nlm-citation></ref><ref id="ref88"><label>88</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Dijk</surname><given-names>SHB</given-names> </name><name name-style="western"><surname>Brusse-Keizer</surname><given-names>MGJ</given-names> </name><name name-style="western"><surname>Bucs&#x00E1;n</surname><given-names>CC</given-names> </name><name name-style="western"><surname>van der Palen</surname><given-names>J</given-names> </name><name name-style="western"><surname>Doggen</surname><given-names>CJM</given-names> </name><name name-style="western"><surname>Lenferink</surname><given-names>A</given-names> </name></person-group><article-title>Artificial intelligence in systematic reviews: promising when appropriately used</article-title><source>BMJ Open</source><year>2023</year><month>07</month><day>7</day><volume>13</volume><issue>7</issue><fpage>e072254</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2023-072254</pub-id><pub-id pub-id-type="medline">37419641</pub-id></nlm-citation></ref><ref id="ref89"><label>89</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomas</surname><given-names>IN</given-names> </name><name name-style="western"><surname>Roche</surname><given-names>P</given-names> </name><name name-style="western"><surname>Gr&#x00EA;t-Regamey</surname><given-names>A</given-names> </name></person-group><article-title>Harnessing artificial intelligence for efficient systematic reviews: a case study in ecosystem condition indicators</article-title><source>Ecol Inform</source><year>2024</year><month>11</month><volume>83</volume><fpage>102819</fpage><pub-id pub-id-type="doi">10.1016/j.ecoinf.2024.102819</pub-id></nlm-citation></ref><ref id="ref90"><label>90</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Manion</surname><given-names>FJ</given-names> </name><name name-style="western"><surname>Du</surname><given-names>J</given-names> </name><name name-style="western"><surname>Wang</surname><given-names>D</given-names> </name><etal/></person-group><article-title>Accelerating evidence synthesis in observational studies: development of a living natural language processing-assisted intelligent systematic literature review system</article-title><source>JMIR Med Inform</source><year>2024</year><month>10</month><day>23</day><volume>12</volume><fpage>e54653</fpage><pub-id pub-id-type="doi">10.2196/54653</pub-id><pub-id pub-id-type="medline">39441204</pub-id></nlm-citation></ref><ref id="ref91"><label>91</label><nlm-citation citation-type="report"><person-group person-group-type="author"><name name-style="western"><surname>Glanville</surname><given-names>J</given-names> </name></person-group><article-title>The role of AI tools in developing search strategies and identifying evidence for systematic reviews</article-title><year>2025</year><access-date>2026-01-13</access-date><publisher-name>Evidence Synthesis Ireland</publisher-name><comment><ext-link ext-link-type="uri" xlink:href="https://evidencesynthesisireland.ie/wp-content/uploads/2025/05/ESI-2025-AI-tools-Julie-Glanville.pdf">https://evidencesynthesisireland.ie/wp-content/uploads/2025/05/ESI-2025-AI-tools-Julie-Glanville.pdf</ext-link></comment></nlm-citation></ref><ref id="ref92"><label>92</label><nlm-citation citation-type="web"><article-title>New Joint AI Methods Group: guiding responsible use of AI in evidence synthesis</article-title><source>Joanna Briggs Institute (JBI)</source><access-date>2026-01-13</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://jbi.global/news/article/new-joint-ai-methods-group">https://jbi.global/news/article/new-joint-ai-methods-group</ext-link></comment></nlm-citation></ref><ref id="ref93"><label>93</label><nlm-citation citation-type="web"><article-title>Roadmap</article-title><source>Evidence Synthesis Infrastructure Collaborative</source><year>2024</year><access-date>2026-01-13</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://evidencesynthesis.atlassian.net/wiki/spaces/ESE/pages/344817670/English">https://evidencesynthesis.atlassian.net/wiki/spaces/ESE/pages/344817670/English</ext-link></comment></nlm-citation></ref><ref id="ref94"><label>94</label><nlm-citation citation-type="web"><person-group person-group-type="author"><name name-style="western"><surname>Scotcher</surname><given-names>S</given-names> </name></person-group><article-title>Evidence Synthesis Infrastructure Collaborative</article-title><source>European Evaluation Society</source><year>2025</year><access-date>2026-01-13</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://europeanevaluation.org/events/evidence-synthesis-infrastructure-collaborative">https://europeanevaluation.org/events/evidence-synthesis-infrastructure-collaborative</ext-link></comment></nlm-citation></ref></ref-list><app-group><supplementary-material id="app1"><label>Multimedia Appendix 1</label><p>Search strategies, included and excluded study information, and methodological quality assessment methods and results.</p><media xlink:href="jmir_v28i1e76130_app1.docx" xlink:title="DOCX File, 53 KB"/></supplementary-material><supplementary-material id="app2"><label>Multimedia Appendix 2</label><p>Frequency of artificial intelligence (AI) or semiautomated tools use.</p><media xlink:href="jmir_v28i1e76130_app2.png" xlink:title="PNG File, 139 KB"/></supplementary-material><supplementary-material id="app3"><label>Checklist 1</label><p>PRISMA-LSR checklist.</p><media xlink:href="jmir_v28i1e76130_app3.docx" xlink:title="DOCX File, 29 KB"/></supplementary-material></app-group></back></article>